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ABSTRACT OF DISSERTATION

A RANDOMIZED CONTROLLED TRIAL OF ANESTHESIA GUIDED BY
BIS VS. STANDARD CARE AND EFFECTS ON COGNITION
Postoperative cognitive dysfunction (POCD) occurs frequently in individuals undergoing
major surgery with general anesthesia. POCD adversely affects morbidity and healthrelated quality of life. Derived electroencephalographic (EEG) monitoring is utilized to
guide the anesthesia provider in titration of volatile anesthetics. POCD has been
associated volatile anesthetic neurotoxicity. EEG monitors are known to reduce a
patient’s total cumulative dose exposure to volatile anesthetics. There is currently little
evidence to support utilization of EEG monitors as a guide to reduce the incidence of
POCD.
The purpose of this dissertation was to develop and test a technique of general
anesthesia, delivered by anesthesia providers and guided by the Bispectral Index™ (BIS)
system EEG monitor. This technique was designed to reduce cumulative volatile
anesthetic exposure and reduce cognitive decline. Prior to testing the intervention,
preliminary work was conducted resulting in a review of evidence for current concepts in
the mechanism of volatile anesthetics and their relationship with POCD. Based on
information from these manuscripts, a randomized, controlled study was conducted to
test the effects of BIS guided anesthetic technique on outcomes of middle aged patients
undergoing impatient major surgery.
Eighty-eight patients scheduled for major inpatient surgery were randomized to a
BIS guided anesthetic, or to usual care control. Although not in every cognitive domain,
BIS guidance resulted in superior and not inferior performance in cognitive testing.
The third manuscript documents predictors of cognitive decline. This was a
secondary, planned data analysis of the previous prospective, randomized controlled trial.
Consistent predictors of cognitive decline through the study phases were older age, lower
income, and lower education. In addition to these, tobacco abuse is a significantly
predictive characteristic.

Further research should be focused on at risk cognitive domains, as well as,
exploring other anesthetic regimens to avoid cognitive decline.
KEYWORDS: heart failure, anxiety, depression, hostility, trajectories, psychological
symptoms
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CHAPTER ONE
Introduction
Anesthesia is one of the greatest advancements in the health sciences. Anesthesia
has not only made invasive procedures tolerable, but also has made countless surgical
advancements possible. The last reported statistical summary by the Centers for Disease
Control and Prevention indicated that there were over 48 million surgical procedures
every year requiring general anesthesia, or the drug induced loss of response and
perception of stimulation.1 The induced state of anesthesia is typically reversible and its
consequences predictable and short-lived. Still, some individuals suffer cognitive deficits
unexpectedly after surgery. Post-operative cognitive dysfunction, hereafter stated as
POCD, is defined as negative changes in cognitive function that continue after
appropriate drug half-lives have expired.
Post-operative cognitive dysfunction was the focus of this dissertation because
POCD adversely affects learning and memory for discharge and follow-up self-care
instructions, short- and long- term recovery, and even mortality risk. In addition, I
focused on POCD because the fastest growing segment of the population are the old and
elderly, which is the group most likely to undergo surgery and also to begin to manifest
mild cognitive impairment (MCI). These old (>60 years of age) and elderly (>75 years of
age) individuals are the greatest consumers of health care.2 Maintaining function and
independence are key components to maintaining quality of life, and the old and elderly
are at greatest risk for POCD.3,4
Many questions important to clinical practice about POCD are yet to be answered.
Foremost among them is whether you are more at risk for POCD if you receive volatile
1

anesthetic agents during surgery. Other unanswered questions include, beyond age, what
risk factors result in increased susceptibility for POCD. Are there techniques to reduce
the impact of anesthesia on cognitive function? What are the most effective means to
evaluate cognitive dysfunction perioperatively? I addressed some of these questions in
this dissertation. The purposes of this dissertation were to (1) determine predictors of
cognitive function among individuals scheduled for surgery using general anesthesia and
volatile anesthetics; (2) determine predictors of cognitive dysfunction after surgery with
general anesthesia and volatile anesthetics; and (3) determine if there are anesthetic
delivery methods that can reduce the incidence of POCD.
Post-operative Cognitive Dysfunction
The symptomology of POCD is similar to that of delirium, and until the late 1990’s
was not separated from the diagnosis of delirium. Improved understanding of POCD
allowed for differentiation from delerium. Delerium is a vascillating inability to focus
and maintain attention compared to POCD, which is a decline in cognitive function
(typically in the memory and executive function domains) that lasts from days to months
and in some cases, years. POCD, as a syndrome, is widely discussed in the literature, but
is not listed in the Diagnostic and Statistical Manual of Mental Disorders (DSM-V).5 This
is because a cognitive condition cannot have characteristics that could place it into
another diagnosis (i.e., delirium, dementia, or amnestic disorder).
Because POCD is not a defined disorder in the DSMMD and because
neurocognitive testing is not routine and not available in all hospitals, POCD is largely
under-appeciated by most clinicians. The objective finding of POCD requires baseline
neurocognitive testing and follow-up testing at intervals after the effective half-lives of
2

anesthetics have passed. Usually, POCD is simply noted by the patient as “clouded
thinking” or by family members as “something just not right”.
Symptoms of derangements similar to POCD have been reported for over 60
years.6,7 Bryson and Wyand describe POCD as a subtle disorder of thought processes that
may influence isolated domains of cognition such as verbal memory, visual memory,
language comprehension, visuospatial abstraction, attention, or concentration, although
the exact areas have not been definitively determined.8 These deficits in advanced
cognitive function and memory continue after surgery and discharge from hospitalization
and may last from days to years.9
In a seminal study, the incidence of POCD ranged from 10-50% depending on type
of surgery.3 More recently, Monk and colleagues4 found that 30 to 41% of all adult
patients experience POCD at discharge after surgery. This cognitive decline is associated
with increased one year mortality, as well as morbidity and family/caregiver stress.4 The
domains that appear to be most affected are attention and cognitive speed but also
affected are executive function and memory.10
Etiology of POCD
The etiology of POCD is unclear. A widely studied hypothesis for the mechanism
underlying POCD alterations is neurotoxic injury. This association between anesthetics
and the dementias has been suspected for over twenty years.11-13 Although there are many
different anesthetics, the inhalation anesthetics (isoflurane, sevoflurane, and desflurane)
are the basis of anesthesia used today. It is well described that inhalation anesthetics have
effects demonstrated in histologic neuropathology similar to those seen in the senile
dementias including Alzheimer’s disease (AD).
3

Multiple neuropathogenic mechanisms of inhalation anesthetic have been described
and are of increasing concern. The most prevalent of these are increased production and
aggregation of amyloid beta (Aβ) peptides, increased caspase activation, and
accumulation of hyperphosphorylated tau. Although there are many anesthetics and
techniques available to obtain surgical anesthesia, some techniques involve use of high
concentrations of volatile anesthetics. These anesthetic techniques lead to higher
cumulative doses of the anesthetic and have been demonstrated to produce higher
histologic neuropathology from inflammatory changes 14-16 Lately, closer correlates have
been drawn between anesthetics, POCD, MCI and AD. This is because the cognitive
domains of memory and executive function that are affected by POCD, MCI, and AD are
similar.
Alzheimer’s disease, the most common form of dementia, is loss of mental ability
affecting the cognitive domains of memory (short-term), verbal (expressive),
visuospatial, and executive function. Mild cognitive impairment is a state of cognitive
ability that falls below norms, but lacks the loss of function seen in the dementias. Mild
cognitive dysfunction is considered a prodromal phase of dementia, and is suspected in
individuals with memory deficits of the core cognitive domains (recall, language,
visuospatial ability, and executive function).
Histological changes associated with AD and MCI are the basis for understanding
the genesis of these conditions. The hallmarks for the histological neuropathology are
Amyloid precursor protein (APP), Aβ, and hyperphosphorylation of tau. Amyloid
precursor protein (APP) is an integral membrane protein believed to be involved in
synapse formation. Amyloid precursor protein is present in dendrites, cell bodies and
4

axons of neurons. Amyloid beta is a peptide enzymatically degraded from the larger APP
that are released in neuronal damage. Amyloid beta deposits are neurotoxic, triggering
retraction of axon terminals at target cells. Amyloid beta is also thought to trigger a
chain-reaction of neuronal destruction in some individuals.17 Cumulatively, this is
described as a senile plaque. Mild cognitive dysfunction is the result of similar
neuropathologic changes.
Triggering of the apoptotic pathway and neuronal loss as a precursor to Aβ
accumulation have been demonstrated in animal models of anesthetics. Isoflurane was
demonstrated by to be an apoptotic neurodegeneration pathway in lower level mammals
that were exposed to therapeutic doses of anesthesia in 2, 4, and 6 hour test groups.18 Xie
and colleagues went on to associate isoflurane with caspase-3, a protein activated in the
execution-phase of cell apoptosis.19 This finding was noted in a 2 hour exposure time and
at a therapeutic isoflurane concentration of 1.4%.
In addition to Aβ, caspase-3 activation with neuronal apoptosis, and cortical
hyperphosphorylated tangles of tau proteins are also noted in the neuropathology of AD.
Research in POCD suggests similar neuropathologic changes. Loop and colleagues
demonstrated that caspase-3 processing is provoked in a concentration/dose-dependent
manner by sevoflurane and isoflurane, resulting in apoptosis.20 Further, sevoflurane
induces caspase activation and apoptosis with subsequent increases of Aβ in human
neuroglioma cells.21 Zhang and colleagues studied the volatile anesthetic desflurane.22 He
found that desflurane alone did not induce caspase or Aβ but may when combined with
hypoxia (18% FiO2). Further, exposure to and subsequent inflammatory changes from
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volatile anesthetics are postulated to progress AD neuropathogenesis through these
pathways.15,23
A common criticism of much of the research in POCD is the poor translation of
bench science to clinical science with patients. This is a common obstacle with dementias
studies, due to the obvious complications trying to translate the results of in-vitro studies
to humans. Despite this difficulty, closer correlations are being noted between the
dementias and POCD. Liu and colleagues concluded that individuals with amnestic MCI
transitioned to progressive MCI in larger numbers in a group exposed to the inhalation
anesthetic sevoflurane than those who had no exposure.24 In this study 55 individuals
with MCI were exposed to an anesthetic with sevoflurane inhalation anesthetic. Of these,
30 individuals were noted to have progressive/amnestic MCI at 2 years (P<0.01) and 13
were diagnosed with AD.
Although, there is weighty evidence suggesting the risks of volatile anesthetics, this
evidence does not warrant the exclusion of the anesthetics. In 2009 a POCD workshop
was conducted with experts from anesthesia, neuroscience, and pharmacology. This
group recognized the evidence linking inhalation anesthetics to the dementias is
considerable on multiple levels of investigation, but that anesthetics provided an
immediate benefit to society that outweigh these risks.36
In summary, although the etiology of POCD is unclear, the evidence supporting
relationship of volatile anesthetics and neuronal inflammatory response is strong. This
inflammatory response is particularly similar to that in MCI and AD. It is hypothesized
that reducing the cumulative volatile anesthetic dose will reduce cognitive dysfunction.

6

Improving POCD Outcomes
Classically, volatile anesthetic depth was titrated to Guedel’s classification, the
presence or absence of various reflexes observed as anesthesia concentrations increased.
Newer drugs, such as the neuromuscular-blocking drugs used today have obscured
reflexes and thus the use of this classification system has declined.
Electroencephalographic (EEG) activity monitors utilize time-domain, frequencydomain, and dual spectral analysis of raw EEG signals to objectively measure level of
consciousness. The application of the Fourier transformation to EEG waveforms and
subsequently, the correlation with depth of anesthesia ushered in development and use of
bedside monitors to guide anesthesia dosing and optimize the depth of anesthesia used so
that it is not too little or too much.
Entropy-guided monitors measure EEG and, through proprietary algorithms,
convert the degree of irregularity seen with the awake EEG and the more regular patterns
seen with increasing depth of anesthesia to a value that can be used by the clinician to
judge depth of anesthesia. Although there are multiple proprietary platforms that are
used to perform entropy-guided anesthesia, the one used in my study was the Bispectral
Index™ system or (BIS). This platform is used by the majority of the market.
There are multiple benefits to the use of BIS-guided anesthesia. Gan and colleagues
established that a secondary benefit of this guided technique was a 13.4% reduction in
anesthetic drug consumption.25 There are many other well-known benefits of entropyguided titration of anesthesia, such as shortened anesthesia emergence time and faster
recovery.26 Investigators have further demonstrated that avoidance of deep anesthesia is
associated with improved survival, reduced morbidity27 and improved 2-year mortality.28
7

Sessler and colleagues described the concept of “triple low” threat, consisting of
hypotension, cumulative deep hypnotic time, and presence of co-morbidities, which leads
to increased odds of one-year mortality.29 Cumulative deep hypnotic time (per hour)
increased one-year mortality by 1.244% (P<0.0121).
In an important study in the field conducted in China, the Cognitive Dysfunction
after Anesthesia (CODA) trial investigators demonstrated increased cognitive
dysfunction after deep anesthesia.30 The investigators utilized BIS-guided anesthesia and
titrated depth of anesthesia to a score of 40-60 (considered good general anesthesia with a
low probability of explicit recall) in 462 individuals and another 459 were randomized to
a blinded control group in which anesthesia was delivered without BIS-guidance. The
outcome of the study was cognitive function measured by a basic cognitive failure
questionnaire including the verbal fluency test, Chinese auditory verbal learning test, and
color trail making test. The CODA trial investigators concluded that controlling
anesthetic depth to a BIS guided range of 40-60 resulted in 83 patients for every 1000
being protected from delirium during hospitalization and 23 avoiding POCD at 3 months
after surgery31.
In another important study, investigators used the BIS to titrate depth of anesthesia.
In this trial, Radtke and colleagues randomized 1277 individuals into two groups, one
that received BIS titrated anesthesia (n=593) and one blinded to BIS values (n=600).32
They found that there was a significant increase in delirium (p=0.015) in the patients
cared for in the blinded group, but no significant differences in POCD were seen
(p=0.062) between the two groups. An interesting limitation of the study was the fact
that the providers in the two groups did not produce differing anesthetic depths, likely
8

because the protocol allowed for unblinding of the provider who was allowed to use data
from the BIS as deemed appropriated.
In summary, entropy guidance monitors have improved the anesthesia provider’s
understanding of depth of anesthesia in real time. Over the past decade the availability
and acceptance of these devises has become widespread. Previous studies have
demonstrated the ability of entropy guidance monitors to positively change the
neurocognitive outcomes for patients. These studies can be improved upon by elimination
of confounding groups and more rigorous cognitive testing.
Measurement of POCD Outcomes
There is no gold standard instrument for the study of POCD. A literature review
of POCD studies by Newman and colleagues reported that at least 70 different measures
were used alone and in combinations.33 There was little similarity in the domains of
cognitive function studied (and in most cases, the investigators failed to report which
domains they studied), in most cases arbitrary definitions of POCD were used and the
definitions were poorly described making replication difficult. All of these problems
create a barrier for POCD researchers in that the findings are difficult to compare
amongst the studies and it is difficult to determine which instruments to use. To date
there is not a neurocognitive battery developed specifically for the study of POCD, nor a
definitive study to indicate the optimum neurocognitive battery.
The Uniform Data Set (UDS) from the Alzheimer’s disease Centers program of the
National Institute on Aging is currently utilized by 32 centers in the United States.34 The
battery is administered by trained neuropsychologist in a clinical office setting. This
battery is exhaustive, diagnostic, and used as part of a 918 variable data collection of
9

research participants, making its use in surgery patients quite difficult and not practical.
Lewis noted that, in regard to studies of POCD, increasing the number of tests in a
battery increases the sensitivity, but resulted in increasing false positive classifications
and error.35 The landmark study of POCD is the International Study of Postoperative
Cognitive Dysfunction study. This study utilized seven different test focusing different
cognitive domains to complete the battery. These test and their domains included the
visual verbal learning test (executive function), concept shifting test (executive function),
Stroop color word interference test (executive function), paper and pencil memory
scanning test (visual memory), letter-digit coding test (processing speed), and four boxes
test (reaction time).
Although, other investigators have utilized the Cambridge Neuropsychological
Test Automated Battery (CANTAB®) system to measure cognitive function, this
dissertation includes the Cambridge Neuropsychological Test Automated Battery-Mild
Cognitive Impairment (CANTAB-MCI®) battery for the first time in the anesthetic
population and for the first time, we identified the specific domains of cognitive function
being measured. The CANTAB® is very sensitive for detecting mild cognitive
impairment, the pre-dementia state most similar to postoperative cognitive dysfunction.
Wide use of such a neurocognitive screening tool in clinical practice may alert providers
in the future to individuals who need an augmented anesthetic, or will need progressive
care postoperatively. This could lead to reduced morbidity, mortality, as well as, patient
and caregiver stress.

10

Overview of the Dissertation
An obstacle in understanding POCD is that the exact mechanism whereby volatile
anesthetics produce their effects is not currently known. Chapter Two of this dissertation
is a review of the state of the science on the mechanism of inhalational anesthetics and
how POCD might occur in that context. This chapter presents an integrative review of the
literature that presents mechanisms that are plausible and their associations with
neuropathogenic effects.
Chapter Three of this dissertation is a report of a randomized controlled trial of an
anesthesia technique guided by the BIS monitor compared with standard care. In a
sample of 86 individuals, 45 surgical patients randomized to the intervention of a
balanced anesthetic technique with BIS guidance, and 43 to standard treatment.
Individuals cognitive performance was evaluated with the Cambridge
Neuropsychological Test Automated Battery-Mild Cognitive Impairment (CANTABMCI®) at three intervals (preoperatively, 3-5 days post-operatively, and 3-5 months postoperatively). An additional 37 age- and sex-matched individuals not undergoing surgery
nor anesthesia were evaluated at the same intervals to represent a normative population.
The purpose of the study was to determine if an anesthetic technique with cumulative
deep hypnotic time result in a greater degree of POCD. A two-way mixed repeated
measures ANOVA was utilized to address this specific aim.
Chapter Four of this dissertation is a review of the predictors of cognitive
dysfunction as defined from the CANTAB-MCI battery. These were determined by
statistical analysis of the randomized controlled trial described in Chapter 3. Predictors of
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cognitive dysfunction are described for baseline, at early postoperative testing time, and
late testing time. Parameter estimates were obtained and described in this chapter.
Chapter Five is an integrated summary and conclusions from the findings of the
manuscript. Recommendations for contemporary clinical practice, as well as, future
research are discussed in this chapter. The findings of the study are targeted as practical
interventions that nurse anesthetists may use in any practice in the United States.
Implications of this research are limiting the effect of anesthetics, in particular volatile
anesthetics, on susceptible surgical populations.

12

CHAPTER TWO
Anesthesia Mechanisms and the Aging Brain
Introduction
The use of anesthetics in the care of individuals undergoing surgery is one of the
greatest accomplishments in the health sciences. Since Joseph Priestley’s work with
nitrous oxide in 1772 and William Morton’s 1846 demonstration of ether anesthesia,
anesthesia has become an increasingly important component of health care. The last
reported statistical summary by the Centers for Disease Control and Prevention1 indicated
that there were over 48 million surgical procedures requiring anesthesia performed in
2009.
Though widely used and accepted as safe, neither the molecular pharmacological
site of action, nor the mechanisms of volatile anesthetic action are currently fully
understood2. There have been no receptors directly identified that account for the activity
of inhalational anesthetic activity. Nonetheless, the practice of anesthesia has evolved and
allowed many of the great surgical advancements of modern medicine.
Improvements in safety of anesthesia over the past five decades are largely
attributed to improved patient monitoring and to optimal training of anesthesia providers.
In the 1950’s anesthesia-related mortality rates were reported as 1 per 1560.3 More recent
studies suggest that anesthesia-related mortality is 1.1 per million per year.4 The practice,
however, seeks to realize a completely benign anesthetic experience.
Growing interest in defining the risk associated with anesthesia is essential in
quality improvement within the practice. Increasing age is an important risk factor for
post-operative morbidity and mortality. By 2030, 20% of Americans will be older than 65
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and 21% of those over 60 will receive anesthesia with surgery (compared with 12% of
those 45-60) A better understanding of anesthesia risks in the elderly can improve
outcomes.
Post-operative cognitive dysfunction (POCD) is one such risk. There is controversy
about the existence of an association between anesthesia and POCD5, yet there is a sound
theoretical and physiologic basis for such an association particularly among older
individuals. Of note, there are similarities in protein abnormalities seen in Alzheimer’s
disease (AD), mild cognitive impairment (MCI) and POCD, which suggest a foundation
for understanding the potential for POCD in older patients.6 The purpose of this paper is
to integrate current concepts of the mechanisms of action of inhalational anesthetics, the
pathology of AD and MCI, and the effects of anesthesia on the aging brain. The major
concept underlying the relationship among these is protein inhibition. Protein inhibition
results in anesthesia. Protein inhibition is associated with multiple deleterious processes,
many of which are seen in AD, MCI and POCD and will be discussed below.
Linking Protein Mechanisms to Postoperative Cognitive Dysfunction and Mild
Cognitive Impairment
Alzheimer’s disease and the prodromal state, MCI are two of the many types of
dementia. Abnormalities in neuronal proteins have been studied in AD and other
dementias for over three decades.7 Amyloid proteins are components of cell membrane.
Normally, these proteins are dissolved in body fluids and utilized in new cell creation.
Occasionally, these proteins become misfolded leading to clumping or aggregates. The
misfolding or transformation of the peptides into aggregate proteins are toxic to other
local, healthy cells The aggregation of amyloid proteins as a result of misfolding is a
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leading theoretical mechanism in the AD pathway. Injury to neuronal cells can create a
destructive cascade of injury to healthy cells that is ultimately manifested by dementia.
Mild cognitive impairment is described as a transitional zone or prodromal state to
frank dementia. Typically, the dementias effect multiple cognitive domains, whereas,
MCI effects a single cognitive domain. MCI is a condition in which an individual
displays memory problems disproportionate to their age.8 This prodromal state bridges
normal cognitive function and the more severe dementias including clinical AD.9 The
typical time period for MCI transition to a more severe dementia is 18 months.10 Volatile
anesthetics have been associated with similar deficits in cognitive domains which have
led researchers to study if there is an association or causal relationship.
Postoperative cognitive dysfunction is a subtle disorder of thought process that
influences isolated domains of cognition such as verbal memory, visual memory,
language comprehension, visuospatial abstraction, attention, or concentration11 after
exposure to an anesthetic and that remains after drug half-lives have past. The cognitive
domains affected in POCD are very similar to those affected in MCI. Symptoms of poor
cognition after surgery have been reported for over 50 years,12 long before POCD was
recognized and named. Postoperative cognitive dysfunction occurs in 27% and 10% of
individuals over 60 years old, at 1 week and 3 months after non-cardiac surgery
respectively,13 and has become a focus of anesthesia research among older and at-risk
populations. Although there is no data to suggest that surgery aggravates existing AD,
inflammation is a critical common pathology of both volatile anesthetic induced POCD
and what is understood from the AD pathway.
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Protein Abnormalities and Anesthesia
The neuronal abnormalities and protein derangements seen in AD are similar to
those seen with use of inhalation anesthetics. Amyloid beta protein (Aβ) aggregates or
plaques are a hallmark of AD pathology. Aβ are a specific type of protein fragments left
from neuronal destruction and are thought to be highly neurotoxic to healthy cells. The
next few paragraphs will highlight significant findings related to POCD pathology.
Anesthetics can induce neurotoxicity via apoptotic neurodegeneration. Apoptotic
neurodegeneration is also known as programmed cell death. This is a process where a
trigger induces the cell to dramatically alter the nucleus or other component leading to the
cell death. Nikizad, Yon, Carter, and Jevtovic-Todorovic14 induced thalamic and cerebral
cortex apoptosis, with clinically appropriate concentrations of volatile anesthetic in rat
pups. The resulting buildup of cellular components creates an imbalance of protein
clearance leading to Aβ and oligomerization.
After neuronal destruction, cellular components are left behind and are further
broken down and cleared in healthy individuals. As mentioned before, in AD a toxic
aggregation of Aβ has been noted to appear in susceptible individuals without a clear
cause. Oligomerization is the bonding of small peptides that will then form larger
aggregates. Eckenhoff et al.15 demonstrated that volatile anesthetics effect
oligomerization or the collection of Aβ, with in vitro rat models. These neurotoxic bodies
are thought to cause further cell destruction and overwhelm the body’s ability to clear
Aβ. Eckenhoff et al.15 enhanced Aβ oligomerization rates and subsequent neurocytotoxicity with exposure to the common volatile anesthetics isoflurane and halothane.
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Caspases, protease enzymes, are the principle executors of apoptotic pathways. Lu
et al.16 showed increased caspase activation in rat pups after a sevoflurane anesthetic. Lu
et al.16 observed increased apoptosis, altered precursor protein processing, and altered βamyloid protein levels. Xie et al.17 demonstrated dose-dependent activation of caspase-3
and apoptosis in human neuroglioma cells with isoflurane. Six hour exposures to
isoflurane at 1% showed no change in caspase-3 activation, although at 2% there was
substantial activation and apoptosis.
The state of the science in POCD research implicates important pathological
outcomes from therapeutic concentrations of volatile anesthetics. Examination of
mechanisms thought to explain the action of volatile anesthetics reveals how these
anesthetics might produce POCD.
The Classic Theory of Anesthetic Mechanisms
Classical theories of anesthetic action have evolved over the last century. The
Meyer-Overton Theory is the oldest concept of inhalational anesthetic action. This theory
suggests that lipophilic molecules of anesthetics penetrate axons and inhibit neural
transmission.18 This theory is supported by the concept of partition coefficient, the ratio
of the unionized/ionized compound in a solution, which leads to a correlation between
anesthesia concentration and potency.19 As newer medications have been evaluated with
the Meyer-Overton Theory, inconsistencies in anesthetic reactions when considered
under the tenets of the theory have limited acceptance of the theory today. In particular
newer halogenated anesthetics (not commonly used in the United States) violate the
proposition of the theory in that immobility or amnesia is not achieved at the predicted
coefficient. Nonetheless, the Meyer-Overton Theory is still relevant today given that it is
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the theory still used to consider issues of anesthetic potency of volatile anesthetics used
currently. This is relevant to POCD because, a careful titration of the volatile anesthetic
can reduce the dose needed, which reduces neuronal saturation resulting in lower risk for
POCD.
Protein Theory of Anesthetic Mechanisms
Protein theories of anesthesia have been described for many years, and with the use
of new investigative instruments, are a major focus of the current study of anesthesia
mechanisms. During the induction phase of an anesthetic, tissues are saturated with
micromolar anesthetic compounds. Due to the lipophilic nature of volatile anesthetics,
there are many hydrophobic protein binding sites available for adherence of anesthetics
beyond the neuronal bilayer. Bilayer, or neuronal cell wall proteins control nerve action
potentials. Many of these proteins have hydrophobic pockets with water soluble amino
acids cores. These hydrophobic pockets, which are typically binding sites for endogenous
fatty acids, could be a site of competitive antagonism for micromolar anesthetic
compounds.
There are also α-helices in cell membrane proteins that may interact with
anesthetics and inhibit protein function. Therefore, there are multiple sites where
anesthetic interaction with neuronal proteins could produce wide-spread changes in lipid
cell wall relationships, implicating anesthetic action in more sites than just the neuronal
bi-layer. The following are just a few of the more convincing areas of volatile anesthetic
binding and influence.
A range of technologies, from crude to advanced, have been used to predict and
visualize volatile anesthetic interaction with proteins. The principle demonstration of
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anesthetic binding with proteins was found using firefly luciferase (the bioluminescent
substance from the insect) by Franks and Lieb20 30 years ago. More recently, Streiff et
al.21 expanded the firefly study by demonstrating that volatile anesthetics bind to the
following other proteins: albumin, apoferritin, and the calcium-calmodulin complex. Of
note, the calcium-calmodulin complex is a component of the signaling cascade of Gproteins, integral to autonomic responses throughout the body. Blunting of the autonomic
nervous system is a critical component of an anesthetic that can adversely affect
cognitive function.
Infrared spectroscopy was utilized by Zou, Liu, and Blasie22 in 2009 to isolate a
binding site for the volatile anesthetic, halothane, in a model of apo-hemoglobin protein.
The model demonstrated that halothane has a weak interaction with the backbone peptide
core but exerts an impact on the electrostatic environment of the protein. This is another
demonstration of binding of volatile anesthetics within membrane protein, but further
illustrates the mechanism of action of halothane by demonstrating that the protein charge
is changed.
Central Cholinergic Nervous System Proteins
There are several protein type ligand-gated ion channels associated with anesthetic
mechanisms. The nicotinic acetylcholine receptors (nAChR) are a broad class of integral
excitatory ligand-gated ion channel proteins. Nicotinic receptors are found in various
physiologic systems, including the central nervous system. These receptors are
responsible for modulation of catecholamine, as well as serotonin, acetylcholine, GABA,
and glutamate neurotransmitters. The nicotinic receptor pathophysiological function
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implicated in anesthetic mechanism, as well as, the links to neuronal injury are listed
below.
GABA, is a subclass of nicotinic wall protein receptor. It is known as the major
inhibitory neuroreceptor. GABA receptors respond to neurotransmitters and diminish cell
action potentials. Normally GABA activation is a gradual process in which negative
membrane potential is maintained to prevent over-excitation. This process involves influx
of chloride ions that hyperpolarize cell membranes thus inhibiting function. Induction of
GABA the effect, is a widely accepted anesthesia mechanism.
There are multiple subclasses of GABA receptor (Figure 1), but the ligand-gated
chloride (Cl) ion channel, GABAA is closely associated with volatile anesthetics. The
GABA receptor has a typical pentameric structure with a central pore. GABAA receptors
contain volatile anesthetic/solvent-accessible space or intrahelical pockets as binding
locations within these pores. Volatile anesthetics are believed to modulate the GABAA
receptor by acting directly or indirectly through a second messenger system. Ernst,
Bruckner, Boresch, and Sieghart24 described these intrahelical pockets as binding pockets
that can exist in numerous drug-induced conformational states. Volatile anesthetics
enhance γ-Aminobutyric acid (GABA) and glutamate inhibition of the central nervous
system, establishing a hyperpolarized neuron23 that produces sedative effects.
Another technology used to improve understanding of the mechanism of anesthesia
at the molecular-receptor level is photolabeling. Li et al.25 utilized photolabeling of a
general anesthetic analog of etomidate ([3H] azietomidate), an intravenous anesthesia
induction agent, at GABAA subunits. Photolabeling supported the early theory of GABA
action by demonstrating the affinity of an anesthetic compound’s for specific amino acids
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in a GABA component protein. The photolabeling technique allows for observation of
the specific anesthetic binding sites on the GABA methionines amino acids. The binding
sites demonstrated were, αM1 transmembrane helix at α1Met-236 and βM3
transmembrane helix at βMet-286 locations.
Providers rarely use etomidate, and halothane is no longer marketed in the US. The
more relevant anesthetics, sevoflurane and desflurane, also have GABA binding sites.
Specifically, these two volatile anesthetics share the position of the GABA receptor
Ser270 of the α1 and α2 subunits, but not the transmembrane 2 of the β2 subunit.26 In
addition to binding at the GABA receptor and influencing neuronal membrane potential,
inhibition of exocytosis of neurotransmitter production occurs.27 Suppression of
neurotransmitter release is another mechanism of volatile anesthetic action at the GABAA
subunits. Amyloid β is thought to weaken GABAA receptors and produces similar
synaptic inhibition in the AD pathway.28 Downregulation and weakened synaptic
inhibition are plausible pathways in the mechanism of anesthesia and POCD.
5-HT3, or serotonin receptors, are another type of ligand-gated ion channel that
belong to the same family as nAChR. These receptors are found in the peripheral and
central nervous systems. Binding of serotonin opens the channel allowing flux of sodium,
potassium, and calcium ions, typically producing excitatory effects. Interestingly, the
electrostatic mechanism of anesthetic binding to receptor sites determines if there is an
excitatory or inhibitory response, demonstrating a mechanism of anesthetic manipulation
of a receptor18. Acrolein, a lipid peroxidation product that is elevated in the AD brain
and is toxic to neurons. The volatile anesthetic sevoflurane has been shown to sequester
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a substance acrolein. Thin sequestration may lead to further production of toxic species
that led to neuronal vulnerability40.
Additional Protein Types
Another type of protein channel is the N-methyl D-asparate (NMDA) receptor.
NMDA receptors are ligand-gated, voltage-dependent integral proteins. In contrast to
GABA receptors, NMDA receptors produce excitatory actions and potentate
depolarization. Dickinson et al.19 utilized molecular modeling to demonstrate that the
volatile anesthetic, isoflurane, competitively inhibits glycine at the NMDA glycine
receptor. Manipulation of NMDA through drugs like memantine, have long been utilized
in an attempt to slow the progression of AD. The association between NMDA and
volatile anesthetics and POCD is still unclear here.
Another, lesser known, possible mechanism of anesthetic action is binding to the
potassium channel subfamily of K member 2 proteins (2PK). 2PK channels, including the
TREK1 and TASK subfamily of channels, are dual-pores that are present in every part of
the central nervous system. These channels remain open to “leak” potassium passively, in
order to maintain membrane potentials. These channels can be intrinsically dilated by
arachidonic acid, lysophospholipids, and polyunsaturated fatty acids. Greater potassium
leak stabilizes cells at hyperpolarized voltages, inhibiting neuronal firing.
Patel et al.20 studied the anesthetic influence of the volatile anesthetics halothane
and isoflurane, as well as, other volatile anesthetics on the neuronal tissue of the Lymnea
stagnalis mollusk. The study reflected increased channel permeability by halothane and
isoflurane via TREK-1 and TASK channel widening. The significance of volatile
anesthetic action at these channels was supported by experiments by Heurteaux et al.21.
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Heurteaux21 utilized mice with a “knock-out”, or genetically eliminated, TREK-1
receptors. The mice demonstrated resistance to the volatile anesthetics chloroform,
halothane, sevoflurane, isoflurane, and desflurane as evidenced by longer induction times
and higher concentrations required to inhibit the righting reflex. TREK-1 receptors are
highly expressed in the hippocampal region of the brain, a region known to be associated
with memory impairment after exposure to volatile anesthetics.41
Discussion
The volume and significance of research provides many mechanisms that may be
responsible for the effects of volatile anesthetics. The mechanisms described above are
not a comprehensive list, but rather those with the most plausible physiology. Each of the
different mechanisms of action listed above is individually or collectively relevant. The
classic theories of anesthetic mechanism, including Meyer-Overton and Critical Volume
Hypothesis, are also still relevant due to their practical application within clinical
practice. With this improved understanding of current concepts in anesthesia mechanism,
the relationships between volatile anesthetics and POCD have been elucidated.
The old and elderly, those >60 years and >75, are the greatest consumers of health
care34. Individuals over age 65 account for 12% of the population, but undergo 40% of
surgical procedures35. The old and the elderly, are more sensitive to anesthetics. The
differences in pharmacokinetic and pharmacodynamic response are largely attributed to
the aging of multiple organ systems. Physiologic changes result in a net reduction in
anesthetic requirement, as well as increased duration of clinical effects. Minimum
alveolar concentration (MAC) is the concentration of an anesthetic where 50% of patients
do not respond to a painful stimulus. This concentration is used as a means to compare
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volatile anesthetic potency by age. With each increase in decade of life, the MAC of an
anesthetic decreases 6.7%. The old and elderly are also more likely to express, through
neurocognitive deterioration, neuronal damage from volatile anesthetics. Moller et al.28
determined advanced age was associated with long term POCD.
In 2008, 16 researchers published a consensus statement regarding anesthesia and
Alzheimer’s disease36. An eight-point summary included evidence from landmark and
recent studies suggested an ominous relationship between anesthesia and Alzheimer’s
disease. These points reviewed the links between volatile anesthetics and the
neuropathologic sequelae. Finally, the group concluded with the importance of
anesthetics outweighing the potential toxic effects and the critical need to continue
studies into this relationship.
There is concern regarding inconsistencies in reliability and validity in this subject.
The anesthetic models and MCI-AD studies have occurred mostly in vitro or in rat
models at best. Studies in humans have been limited to protein biomarkers (cerebrospinal
fluid), imaging, and neurocognitive testing37. The associated evidence of anesthesia
neurological protein changes have occurred in tests tailored after similar AD studies, not
those specifically developed for POCD. Also, there are questions regarding the relevance
of neuronal damage and the degree of neurocognitive decline.
Understanding the mechanism of volatile anesthetics is not essential to the practice
of anesthesia. This has been demonstrated over the past 100 years. Evolving
understanding of mild cognitive impairment-Alzheimer’s disease and postoperative
cognitive dysfunction makes anesthetic practice by ex juvantibus tenuous. Questions of
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best practice, anesthetic selection, and even surgical modality all are increasingly relevant
as POCD is better understood.
Still, there anesthetics induce apoptosis and/or β-amyloid aggregation, neuronal
derangements. Anesthesia is definitely not benign. As more definitive models of
anesthetic mechanism and MCI-AD pathways are studied, techniques to limit or avoid
neurotoxic anesthetic exposure can be tested and evaluated in hopes of reducing negative
anesthetic outcomes.
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Figure 2.1.GABAA Receptor

Source: http://neurocycletherapeutics.com/science/gabaa-receptor/
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CHAPTER THREE
A Randomized Controlled Trial of Anesthesia Guided By BIS vs. Standard Care and
Effects on Cognition
Introduction
Postoperative cognitive dysfunction (POCD) is a subtle deterioration of cognitive
function observed after exposure to inhalation anesthetics. In POCD, deficits in advanced
cognitive functions and memory continue after appropriate anesthetic drug half-lives
have expired, and may last from days to years.9 The incidence of POCD ranges from 1050% depending on definitions, study designs, sample sizes, and neurocognitive measured
used.36 This cognitive decline is associated with increased one-year mortality, as well as
morbidity and family/caregiver stress.37 Socially, these deficits also lead to earlier
retirement, and greater reliance on social financial support systems.38 The cognitive
domains thought to be most affected are attention, cognitive speed, executive function
and memory.39 It is estimated that over 51 million individuals will undergo a procedure
necessitating anesthesia annually, thus exposing a large segment of the population to
potential POCD.1
Inhalation anesthetics have neuropathogenic effects similar to the changes seen in
senile dementias, including Alzheimer’s disease. Based on these known properties of
inhalation anesthetics, our overall hypothesis is that anesthetic techniques with greater
cumulative deep hypnotic time result in a greater degree of POCD. It is possible to
decrease cumulative deep hypnotic time by using derived electroencephalographic (EEG)
monitoring to titrate volatile anesthetics. One of the major modalities for delivering EEGguided anesthesia is the Bispectral index™ system (BIS) (Covidien®). Using this system,
cumulative deep hypnotic time can be reduced or eliminated without negatively affecting
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patient physiologic stress or the surgical conditions. Derived EEG guided anesthesia has
been demonstrated to improve recovery,40 reduce anesthetic consumption,41 and reduced
delirium and confusion post-operatively.31
Despite the apparent benefits of BIS-guided anesthesia this technique is rarely used
in practice. Reasons that this approach has not been adopted widely include
misconceptions that BIS-guided anesthesia is used only to prevent surgical awareness of
patients, beliefs that enhanced vigilance is required, lack of awareness by anesthesia
providers about the effectiveness of such techniques, and the limited research testing this
technique in randomized, controlled trials.
In order to provide rigorous data on the neurocognitive outcomes associated with
BIS-guided anesthesia, we conducted a randomized controlled trial of BIS-guided
anesthesia versus standard anesthesia using concentration-guided techniques. We used
BIS in a tight reference range to avoid deep anesthesia (i.e., BIS <40) by maintaining a
BIS range of 45-60. In addition, we used a state-of-the-art, highly sensitive
neurocognitive testing system that is easy for patients of all ages to use in order to obtain
valid and reproducible outcomes.
The specific aims of this study were:
Specific Aim 1. To compare neurocognitive scores 3-5 days and 3-5 months postoperatively between individuals undergoing anesthetic for surgery lasting greater than 2
hours who were randomized to BIS guided anesthesia (group 1) or standard anesthesia
care (group 2),
Specific Aim 2. To compare neurocognitive scores among group 1 (BIS guided
depth), group 2 (standard anesthesia care) and a third, non-randomized, normative group
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(group 3) of individuals who did not have surgery or anesthesia, and who were age- and
sex-matched to the surgical groups.
Methods
Design. This study was a prospective, randomized controlled trial. Parallel study
groups underwent anesthesia for select surgeries and completed the Cambridge
Neuropsychological Test Automated Battery-Mild Cognitive Impairment (CANTABMCI®) at three intervals. The standard treatment group underwent anesthesia with
inhalation anesthetics titrated around minimum alveolar concentration (MAC) values.
Patients in the intervention group were titrated to BIS values 45-60, but not less than 0.5
age adjusted MAC as measured by the Drager Apollo version 4.1. The CANTAB-MCI®
was used to measure cognitive function and was done preoperatively, at 3-5 days
postoperatively, and at 3-5 months post-operatively. The sample included 86 individuals,
45 surgical patients randomized to intervention and 43 to standard treatment. An
additional 37 age- and sex-matched individuals not undergoing surgery nor anesthesia
were followed with neurocognitive testing at similar intervals to serve as a normative
group.
Sample and Setting. Patients aged 45-70 years undergoing general anesthesia for
an elective surgical procedures scheduled to last approximately 2 hours at an academic
medical center, who met selection criteria and agreed to participate were eligible for
enrollment. After baseline data collection, patients were randomized to receive general
anesthesia with either BIS guided titration or standard clinical practice. Computer
randomization was utilized for randomization. The normative group was recruited from
the community and a large group of them were the spouses of the participants.
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Inclusion criteria. Inclusion criteria for patient participants was assessment as
American Society of Anesthesiologist (ASA) class I-IV patients. These patients were
selected from scheduled surgeries requiring general endotracheal anesthesia with
neuromuscular paralytic. Individuals for the normative group were included if they were
age 45-70, had not undergone surgery in the past 6 months, and had no surgery planned.
Only participants (patients and non-patients) successfully completing the Motor
Screening (MOT) test from the CANTAB-MCI® were invited to participate in the study.
Exclusion criteria. We excluded individuals with significant cardiorespiratory or
other end-organ disease (i.e., unstable angina, uncontrolled diabetes, severe peripheral
vascular disease), inadequate English language skills, and/or substance abuse. We also
excluded individuals with pre-existing neurological conditions (i.e., stroke, pre-existing
cognitive dysfunction, and neuro-motor disabilities) and neurosurgical candidates.
Recruitment. Patients were referred to the study by physicians and/or nurse
practitioners working in the Preoperative Clinic and surgeons in the medical center.
Study staff recruited individuals fitting inclusion/exclusion criteria after completing
preoperative interview screening.
Intervention. Anesthetic technique for both surgical groups included standard
induction with available agents, neuromuscular paralysis guided by nerve stimulator,
inhalation anesthetic, and intraoperative monitoring in accordance with the Department
of Anesthesiology and ASA guidelines. Invasive monitoring, including arterial pressure,
and central venous pressure was performed at the discretion of the anesthesia provider.
BIS monitors were applied to both groups. The anesthesia provider in the standard
practice group was blinded to the BIS value via study blind. Titration and administration

30

were performed according to standard clinical practice judgment and optimal patient
recovery in the standard treatment group. In the BIS group, the anesthesia provider
titrated the volatile anesthetic to maintain a BIS index range 45-60, but not less than 0.5
age adjusted MAC.
Select physicians and nurse anesthetists performed anesthesia, grouped by
treatment and control. These individuals volunteered and underwent a well-defined
training period and used well-defined anesthetic plans. Data were collected from the
anesthetic record after each case. Intra-operatively, anesthesia clinicians aborted the study
protocol as they deemed necessary for participant stability and safety.
Measures
Demographic data. Information including the following variables were collected
by patient interview questionnaire: Age, sex, race/ethnicity, marital status and whether
patient lives alone, education level, and annual income.
Clinical data. American Society of Anesthesia physical status classification,
previous anesthetics, current prescriptive medication regimen, physical exam, and
comorbidities were obtained from the anesthetic record. All drugs utilized during the
procedure were recorded on the anesthesia record and then transferred to a database for
analysis. In particular, inhalation anesthetic type as well as mean, median, and mode
inspired and expired concentrations were recorded. Mean, median, and mode BIS scores
were also collected from the anesthesia record. Total intraoperative anesthetic time was
recorded. Perioperative narcotic exposure was discriminated by narcotic type and dose.
Neurocognitive testing. Neurocognitive testing is an evaluation of a patient’s
cognitive status by specific domain. Cognitive domains include attention/vigilance,
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reasoning and problem solving, verbal learning and memory, visual learning and
memory, language and verbal comprehension, working memory, speed of processing,
general intellectual functioning, automaticity and procedural learning, psychomotricity,
and perceptual processing. The CANTAB-MCI® system was used to measure cognitive
function, and is a computerized, touch screen based group of 5 tests.
The CANTAB-MCI® battery includes the Motor Control Task (MOT), Delayed
Matching to Sample (DMS), Rapid Visual Information Processing (RVP), Paired
Associates Learning (PAL), and Reaction Time (RTI). Tests are scored by number of
correct responses and/or time to complete task as appropriate. Test/re-test reliability of
versions of CANTAB-MCI® test have been reviewed favorably in previous studies of
postoperative cognitive dysfunction and validity of the method has been established.42
The MOT (2 minutes) is a simple introduction to the touch screen for
the participant. This task also functions as a screening test for visual, movement and
comprehension difficulties. Each participant successfully completed this task prior to
enrollment in the study, and again successfully completed the task before each
subsequent testing session.
The DMS (10 minutes) assesses cognition in the memory domain for nonverbalizable patterns, testing both simultaneous and short term visual memory domains.
These non-verbalizable patterns are shown, and after a brief delay, one of four patterns
are matched to the original. This test assesses latency or the participant's speed of
response/speed of processing domains. We used the outcome measure, ‘DMS percent
correct’. This outcome measure reports the total number (as a percentage), of correct
selections made on the participant’s first response (higher score is better).
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The RVP (7 minutes) tests sustained attention by assessing the participant’s ability
to recall a sequence of digits when given different combinations of digits. The RVP is
sensitive for the visual sustained attention domain. We used two outcome measures to
reflect this domain, ‘RVP A’ ’ and ‘RVP median latency’. The RVP A’ (this denotes
RVP A prime) measures the sensitivity to the target, regardless of response tendency
(scored 0.00 to 1.0; bad to good), or how good the participant is at detecting target
sequences. The RVP median latency is measured in milliseconds, and shorter is better.
The PAL (10 minutes) assesses the short term/visual memory domain. The PAL is
useful for assessing individuals with questionable dementia, MCI, Alzheimer's disease,
and age-related memory loss. Patients are asked to associate visual patterns that cannot be
verbalized with spatial locations on the computer screen. We used two outcome measures
to reflect this domain, ‘PAL total errors 6 shapes adjusted’ and ‘PAL total errors
adjusted’. The ‘PAL total errors adjusted’ measures the total number of errors across all
assessed problems and all stages with adjustment for each stage not attempted due to
previous stage failures. The lower the score the better. The ‘PAL total errors 6 shapes
adjusted’ is a measure in an advanced stage of the test and can discriminate subtle
decrements in cognition in high functioning individuals. The lower the score the better.
The final domain test is the RTI (5 minutes). The RTI test is a speed of
processing/latency domain task with a comparative history (the five choice task) and uses
a procedure to separate response latency from movement time. This allows for control for
participants with tremor. This test involves the use of a press pad controlled by the
participant’s dominate index finger
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The ‘RTI mean simple reaction time’ measures the speed at which the participant
releases the press pad button in response to a stimulus from a single location. This test is
the mean of the measure reflecting cognitive recognition, lower scores reflecting better
performance. ‘RTI median simple reaction time’ measures the same speed of press pad
button response. The test reflects the median of the measure of cognitive recognition and
is sensitive for slowing, with lower scores reflecting better performance. ‘RTI median
simple movement time’ is the median time, measured in milliseconds, taken to touch the
stimulus after the press pad has been released in response to a single stimuli. This is a
measurement of the motor speed and is sensitive for slowing. The lower the score, the
better. ‘RTI median five choice movement’ is the median of the measurement of speed
with which the press pad button is released in response to a stimulus in any of five
locations. Lower score is better.
Protocol. The study proceeded after approval from the appropriate university
Institutional Review Board, and after informed consent was received. Informed consent
was obtained by Collaborative Institutional Training Initiative (CITI) trained study staff
from all patients and non-surgical participants fitting inclusion criteria who agreed to
participate. All research records were secured on computers with university encryption
systems. After successful completion of the screening Motor Control Task (MOT), a full
consent was completed when the patient agreed to participate.
The CANTAB-MCI® battery was administered upon attaining consent (baseline,
test time 1). A version of the battery was administered on post-anesthetic day 3-5 (test
time 2), in the patients’ hospital room, service’s clinic, or location convenient to the
patient. Three to five days is an appropriate time period that would ensure drug half-lives
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have expired. The battery was again re-administered at 3-5 months (test time 3) at a
location convenient to the patient.
Data Analysis. Data analysis included a descriptive summary, including means and
standard deviations or frequency distributions, as appropriate. Comparisons of the groups
at baseline was done using two-sample t-tests, chi-square tests of association or ANOVA.
To address each of the two Specific Aims, two-way mixed (i.e., one within subjects
variable [time] and one between subjects variable [group]) repeated measures analysis of
variance (ANOVA) was used. Each of the assumptions of repeated measures ANOVA
(no significant outliers, the dependent variable is approximately normally distributed for
each level of the independent variable, homogeneity of variances and covariances, and
sphericity) were tested. The only violations across the various dependent measures were
violations of the sphericity or homogeneity of variances assumptions. Both violations
were managed using the appropriate p value correction. For example, when the sphericity
assumption was violated, the p value was determined using the Greenhouse-Geiser
correction.
When a significant group by time interaction was found, appropriate post-hoc pairwise and group-wise testing was done. Data analysis was conducted using SPSS, version
22; an alpha level of < 0.05 used throughout.
Power considerations. With an alpha level of 0.05 and 34 individuals in each
groups by the final assessment, the power of the repeated measures ANOVA F test to
detect a significant main effect or interaction was at least 80%, assuming that the ratio of
group means to the standard deviation of the observations within the populations was at
least 0.25. Cohen43 considers this a medium effect size. This power analysis was
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conservative because the methodology used to estimate the repeated measures models is
robust with respect to missing data, as long as they are missing at random. The power
estimates are expected to slightly underestimate the actual power, because we increased
the sample size to allow for attrition with the goal of having at least 34 per group
complete the study. Power analysis was conducted using nQuery Advisor, v. 6.02.
Results
Flow of participants through the study. We screened patients from October 2014
through June 2015 with the last follow-up completed in September 2015. Of the 329
patients eligible for enrollment, 143 did not meet eligibility criteria and 98 chose not to
participate (Figure 1). Of the 88 patients scheduled for surgery who were enrolled, 45
were randomized to the intervention limb of the protocol and 43 were randomized to the
control protocol. Of the 45 patients allocated to the intervention limb, 2 (4.46%) were lost
to follow-up prior to the anesthetic. In the control limb, 1 (2.3%) was lost prior to the
anesthetic. Two patients from the intervention (4.46%) and control (4.6%) protocol limbs
were lost to follow up prior to their cognitive testing session 2. Two (4.46%) more
patients were lost to follow up prior to testing session 3 in the intervention limb of the
protocol. There was no difference in rate of withdrawal from the two surgical groups
(p=0.33). Patients who withdrew from the study were not significantly different than
patients who remained in the study on any of the demographic or clinical characteristics
measured at baseline including testing time 1 CANTAB-MCI® scores.
In addition we used purposive sampling to enroll an age matched healthy control
sample. Seventy-two individuals were approached, with 10 not meeting inclusion criteria
and 25 refusing participation. Thirty-seven individuals were enrolled with one lost to

36

follow up prior to testing time 2. This 36 participant group was age- and gender-matched
to the surgical patient groups.
Sample Characteristics. Of the 79 surgical patients available for analysis of
cognitive outcomes at the last follow-up point (90% of the enrolled sample), the mean
age was 59.1 ± 6.7 years of age, the majority were female (64.3%) and
married/cohabitating 83 (72.2%). Seventy-seven percent had combined household
incomes of less than $75,000 per year. The most common ASA classification was ASA II
(46.8%), while 36.5% were classified as ASA III, and the remainder ASA I. The highest
level of education attained was high school graduation/equivalent in 68.7%.
Demographic and clinical characteristics of patients by total sample and group
assignment are summarized in Table 1. There were no significant differences among the
groups on any demographic or clinical characteristic.
Anesthetic Vapor. Demonstrating the expected difference between the intervention
group and the control, standard anesthesia techniques group, there were significant
differences in mean concentration of inspired and expired anesthesia vapors between the
groups summarized in Table 2. Specifically, the mean inspired and expired
concentrations of anesthesia vapor were lower in the EEG guided group. Also
demonstrating the expected difference between the groups, the BIS value was
significantly higher in the treatment versus the control group (48.0 ± 4.6 vs 41.5 ± 6.9, p
< 0.001).
With regard to safety of the intervention, there were no adverse effects seen in
either group intra-operatively. Satisfactory anesthesia was provided for every patient in
both groups. There were no instances of operative recall in either group at 3-5 days or 3-5
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months post-operatively, even in the intervention group with age-adjusted MAC levels as
low as 0.5.
Effect of EEG guided Therapy vs. Standard Anesthesia
Specific Aim 1.
The impact of the intervention on cognitive function was measured in four
cognitive domains: memory (DMS percent correct), attention (RVP A’ and RVP median
latency), visual memory (PAL total errors 6 shapes adjusted and PAL total errors
adjusted), and speed of processing (RTI mean and median simple reaction times, RTI
median simple movement time, and RTI median 5 choice movement).
Memory (non-verbalizable/patterns). Using repeated measures ANOVA, there was
neither a group by time interaction or a time main effect for the outcome ‘DMS Percent
Correct’ (Table 3, Figure 2).
Attention (visual sustained). Using repeated measures ANOVA, for both indicators
of this domain ‘RVP A’ ’ (p=0.58) and ‘RVP median latency’ (p=0.55) there was no
group by time interaction (Table 3, Figures 3 and 4). There was however, a main effect of
time for both indictors (p=<0.001 and p=0.003 respectively).
Short term/visual memory domain. Using repeated measures ANOVA, we
demonstrated significant group by time interactions in the multivariate overall test for
both indicators, ‘PAL total errors 6 shapes adjusted’ (p=0.02) and ‘PAL total errors
adjusted’ (p=0.02), of this domain (Table 3, Figures 5 and 6).
Post-hoc testing to determine at which time points the groups differed revealed that
with regard to the ‘PAL total errors 6 shapes adjusted’ (Figure 5), the scores between the
two groups were similar at baseline (p=0.75), but the trajectory across time diverged at
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time two (p=0.019) in that the intervention group had better scores (lower) than the
standard care/control group. At time three, there were again no differences between
groups (p=0.32).
Post-hoc testing to determine where changes lie across time in each group, revealed
that in the intervention group, there was a significant improvement in scores between
time 1 to 2 (p=0.016), and time 1 to 3 (p=0.001), but not between time 2 and 3 (p=0.517).
In the control/standard care group there was not a difference between time 1 and 2
(p=0.196), but there was a significant improvement between time 2 to 3 (p=0.01) and 1 to
3 (p=0.035).
In regard to ‘PAL total errors adjusted’ (Figure 6), the trajectories seen mirror those
for ‘PAL total errors 6 shapes adjusted’. Post-hoc testing to determine at which time
points the groups differed revealed that in regard to the ‘PAL total errors adjusted’
(Figure 2), the scores between the two groups were similar at baseline (p=0.76), and at
time 2 (p=0.21). At time 3 the groups diverged (p=0.01) with the intervention group
having better scores (lower) than the standard care/control group.
Post-hoc testing to determine where changes lie across time in each group revealed
that in the intervention group, there was a significant improvement in scores between
time 1 to 2 (p=0.01), and time 2 to 3 (p=0.07), but not between time 1 and 3 (p=0.38). In
the control/standard care group there was a worsening of scores between time 1 and 2
(p=0.02), and an improvement from time 2 to 3 (<0.001), and from time 1 to 3 (p=0.01).
Speed of processing/latency. The indicator ‘RTI mean simple reaction time’
demonstrated a significant group by time interaction (p=0.03). None of the other
indicators were found to have significant group by time interactions (Table 3, Figure 7).
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Regarding these three, ‘RTI median simple reaction time’ (p=0.07), ‘RTI median simple
movement time’ (p=0.15), and ‘RTI median five choice movement time’ (p=0.06), there
was no group by time interactions (Table 3, Figures 8, 9, and 10). There was a main
effect of time for all (p=<0.001, p<0.001, p=0.001, and p=<0.001, respectively).
Specifically, for both groups cognitive function worsened at time point two and returned
to baseline by time three.
Post-hoc testing to determine at which time points the groups differed revealed that
in regard to the ‘RTI mean simple reaction time’ (Figure 7), the scores between the two
groups were similar at baseline (p=0.92), but the trajectory across time diverged at time
two (p=0.04) in that the intervention group had better scores (lower) than the standard
care/control group. At time three, there were again no differences between groups
(p=0.4).
Post-hoc testing to determine where changes lie across time in each group, revealed
that in the intervention group, there was a significant slowing of cognition in scores
between time 1 to 2 (p=0.02), but not between time 2 and 3 (p=0.11), or time 1 to 3
(p=0.56). In the control/standard care group there was a similar slowing between time 1
and 2 (p=<0.001), and also from time 2 to 3 (p=<0.001), but there was no difference
between time 1 to 3 (p=0.7).
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Comparison of neurocognitive scores among group 1 (EEG guided), group 2 (standard
anesthesia care) and group 3 (no anesthesia/surgery).
Specific Aim 2.
Memory (non-verbalizable/patterns). Using repeated measures ANOVA, there was
neither a group by time interaction nor a main effect for the outcome ‘DMS Percent
Correct’ (P=0.3 and 0.5 respectively). (Table 4, Figure 11).
Attention (visual sustained).Using repeated measures ANOVA, for the indicator of
this domain ‘RVP A’ ’ (p=0.03) (Table 4, Figure 12) there was a group by time
interaction, but not for ‘RVP median latency’ (p=0.1) (Table 4, Figure 13). There was
however, a main effect of time for both indictors (p=<0.001 and p=0.007 respectively).
Post-hoc testing to determine at which time points the groups differed revealed that
in regard to the ‘RVP A’ ’ (Figure 12) there were group differences in the scores at
baseline between intervention and normative (p=0.03), control/standard care and
normative (p=0.004), but no difference between intervention and control (p=0.46), but at
time three, there were no differences between groups (p=0.21). Time two group
differences were similar in that intervention to normative groups (p=0.001) and
control/standard care to normative (p=<0.001). Again, there was no significant
differences between intervention to control/standard care at time two (0.4). Finally, there
were no significant group differences at time three. Intervention to normative (p=0.2),
control/standard care to normative (p=0.1), and intervention to control/standard care
(p=1) all did not find significance.
Post-hoc testing to determine where changes lie across time within each group,
revealed that in the intervention group, there was significance between time 2 to 3
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(p=<0.001), but not time 1 to 2 (p=0.13), or between time 1 and 3 (p=0.07). In the
control/standard care group there was not a difference between time 1 and 2 (p=0.15), but
there was a significant improvement between time 2 to 3 (p=0.001) and 1 to 3 (p=0.007).
In the normative group, there was not a significant difference over time (p=0.342)
Short term/visual memory domain. Using repeated measures ANOVA, we
demonstrated significant group by time interactions in the multivariate overall test in both
indicators ‘PAL total errors 6 shapes adjusted’ (p=<0.001) and ‘PAL total errors
adjusted’ (p=0.005), of this domain (Table 4, Figure 14 and 15). There were also main
effect of time for both ‘PAL total errors 6 shapes adjusted’ (p=<0.001) and ‘PAL total
errors adjusted’ (p=0.005) (Table 4).
Post-hoc testing to determine at which time points the groups differed revealed that
in regard to the ‘PAL total errors 6 shapes adjusted’ (Figure 14), there was not a
significant difference amongst groups at base line. These values were intervention to
normative (p=0.4), control/standard care to normative (p=0.6), and intervention to
control/standard care (p=0.7). At time two the trajectory of the control/standard care
group diverged from both the intervention group (p=0.01) and the normative group
(p=<0.001). At time three there were no differences between groups, intervention to
normative (p=0.3), control to normative (p=0.9), and intervention to control (p=0.4).
Post-hoc testing to determine where changes lie across time in each group, revealed
that in the intervention group, between time 1 to 2 (p=0.016), and time 1 to 3 (p=0.001),
but not between time 2 and 3 (p=0.5). In the control/standard care group there was not a
difference between time 1 and 2 (p=0.2), but there was a significant improvement
between time 2 to 3 (p=0.01) and 1 to 3 (p=0.04). The normative group demonstrated
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significant differences between time 1 and 2 (p=<0.001) and time 1 and 2 (p=0.001), but
not time 1 and 3 (p=0.2).
In regard to ‘PAL total errors adjusted’ (Figure 15), the trajectories seen mirror
those seen for ‘PAL total errors 6 shapes adjusted’. Post-hoc testing to determine at
which time points the groups differed revealed that in regard to the ‘PAL total errors
adjusted’ there was no difference among the groups at time one. Intervention compared to
control (p=0.7), intervention to normative (p=0.5) and control to normative (p=0.3) all
were not significant. The scores at time two demonstrated difference between the
intervention to control (p=0.004) and control to normative (p=<0.001), but not between
the Intervention to normative (p=0.3). At time three the groups again were not significant
with the Intervention group to control (p=0.2), the Intervention to normative (p=0.7) and
control group to normative (p=0.4).
Post-hoc testing to determine where changes lie across time in each group, revealed
that in the intervention group, there was a significant improvement in scores between
time 1 to 2 (p=0.01), but not time 2 to 3 (p=0.07), or between time 1 and 3 (p=0.4). In the
control/standard care group there was a worsening of scores between time 1 and 2
(p=0.02), and an improvement from time 2 to 3 (<0.001), and from time 1 to 3 (p=0.01).
Speed of processing/latency. Two indicators were found to have significant group
by time interactions. ‘RTI median simple reaction time’ (p=0.005), and ‘RTI median five
choice movement time’ (p=0.005) both had group by time interactions (Table 4, Figures
16 and 17). Two indicators, ‘RTI mean simple reaction time’ (p=0.1) and ‘RTI median
simple movement time’ (p=0.1), did not have a significant group by time interaction
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(Table 4, Figures 18 and 19). There was a significant main effect of time for all of these
outcome measures (Table 4).
Post-hoc testing to determine at which time points the groups differed revealed that
in regard to the ‘RTI median simple reaction time’ (Figure 16), the scores between the
three groups were similar at baseline in that Intervention to control (p=0.6), Intervention
to normative (p=0.7) and control to normative (p=0.4). Time two trajectory of the control
group diverged with Intervention to control (p=0.02) and the control to normative
(p=<0.001). The Intervention group mirrored the normative scores (0.1). At time three,
there were again no differences between groups. The Intervention to control (p=0.6),
Intervention to normative (p=0.9), and control to normative (p=0.5) did not demonstrate
significance.
Post-hoc testing to determine where changes lie across time in each group, revealed
that in the intervention group, there was a significant slowing of cognition in scores
between time 1 to 2 (p=<0.001), and between time 2 and 3 (p=<0.001), but not between
time 1 to 3 (p=0.8). In the control/standard care group similarly slowing between time 1
and 2 (p=<0.001), and also from time 2 to 3 (p=<0.001), but there was no difference
between time 1 to 3 (p=0.7). The normative group performed similarly, with scores from
time 1 to 2 (p=0.2) and 2 to 3 (p=0.05) significant. Scores at time 1 to 3 were not
significant (p=0.8).
In regard to the outcome measure ‘RTI median five choice movement time’, posthoc testing to determine at which time points the groups differed revealed (Figure 17),
the scores between the three groups were similar at baseline in that Intervention to control
(p=0.3), Intervention to normative (p=0.1) and control to normative (p=0.6). Time two
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trajectory of the control group diverged with control to normative (p=0.002). The
Intervention to normative (0.2), and Intervention to control (p=0.9) were not significant.
At time three, there were again no differences between groups. The Intervention to
control (p=0.5), Intervention to normative (p=0.4), and control to normative (p=0.1) did
not demonstrate significance.
Post-hoc testing to determine where changes lie across time in each group, revealed
that in the intervention group, there was not a significant difference in scores between
time 1 to 2 (p=0.5), nor between time 1 and 3 (p=0.07), but there was a significant
difference between time 2 to 3 (p=0.001). In the control/standard care group significance
between time 1 and 2 (p=0.004), and also from time 2 to 3 (p=<0.001), but there was no
difference between time 1 to 3 (p=0.1). There was not a significant change in normative
group with scores from time 1 to 2 (p=0.6) and 2 to 3 (p=0.8), and 1 to 3 (p=0.6).
Discussion
Cognitive decline seen in the dementias is associated with increased mortality.44
Similarly, POCD is associated with higher morbidity and mortality.4 It is not clear if
cognitive decline directly causes this increased mortality or is a peripheral contributor. In
concert with these data, our data suggests that early POCD, even when transient, may
identify patients who are vulnerable to later morbidity and mortality. If future studies
support this association then those individuals with early POCD could be targeted for
intervention to reduce later morbidity and mortality. Interventions to reduce the impact of
POCD should focus on support, and referral to multidisciplinary providers where defects
are found.
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We examined the impact of BIS-guided anesthesia on cognitive outcomes using a
state-of-the art neurocognitive testing computerized platform and unlike others, we tested
specific cognitive domains. We demonstrated significantly lower volatile anesthesia
exposure in the intervention (BIS-guided anesthesia) compared to the control group
(p=<0.001). We demonstrated the safety of the intervention in that there were no adverse
events associated with its use. We also demonstrated cognitive decline in the visual
memory domain in the control versus BIS-guided anesthesia group in the 3 – 5 day postsurgery period compared to baseline, but not at the 3-5 month period. This reflects that
POCD occurs in specific domains but may be time limited, reflecting the findings of
some previous studies.3,4
Reflecting the main effect of time seen in the regression analyses with both the two
surgical groups alone, and the three group analyses, both surgical groups demonstrated
postoperative depression in cognitive function in every outcome measure (with the
exception of DMS), but in every instance, the standard care group’s was more
pronounced. These findings indicate there is a higher cognitive obstacle in the memory
domains encountered by patients exposed to a higher cumulative dose of volatile
anesthetic. The outcome measures ‘PAL total errors adjusted’ and ‘PAL total errors 6
shapes adjusted’ were both sensitive to the treatment technique. The PAL component of
the CANTAB-MCI battery reflects the greatest impairment, and severity of dysfunction,
in MCI and AD45. The finding of ‘PAL total errors adjusted’ is of greatest concern due to
a close relationship with amnestic MCI (aMCI)46. Hippocampal atrophy and loss of
function is a known pattern beginning in MCI and advancing in AD. The recall of objects
in space is a process involving the hippocampus directly tested in the PAL.47 Junkkila
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and colleagues found the ‘PAL total errors adjusted’ variable accounted for the largest
difference between aMCI and mild AD.48 This outcome measure reflects a significant
cognitive decline in the visual memory domain. The association of these findings and the
known neuropathologic inflammatory sequel of these anesthetics suggest these volatile
anesthetics are not benign.
The memory impairments noted in our study with the use of standard anesthesia not
guided by EEG have the potential to adversely influence patient discharge. If patients
have memory impairments, they will be unable to adequately process and remember
important discharge instructions. Even when instructions are written, they are very
commonly standard instructions that lack the specificity and detail needed for each
individual patient. Patients and family members have substantial difficulty remembering
instructions even under ideal situations,49 and our results suggest that most post-operative
patients have enough POCD to impair their ability to retain the information needed for
successful discharge and recovery.
Our findings differ from two of the most recent studies investigating use of derived
EEG guidance as a means to reduce the incidence of POCD. A large German study led by
Radtke failed to find significant difference POCD between derived EEG guidance and
standard care at day 7 (p=0.372) nor day 90 (p=0.062).32 Our study differs in that we
utilized volatile anesthetics exclusively for maintenance, rather than introducing macromolar anesthetics (propofol), which could be considered a confounder. Other
differentiation between the studies was that we utilized the complete CANTAB-MCI
battery and examined differences in specific domains that we explicated a priori.
Previous investigators who used the CANTAB-MCI reported cognitive function as a
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global phenomenon (despite the fact that the CANTAB-MCI has no such measures)
failing to take advantage of the precision offered by assessing cognitive function in
domains. The CANTAB-MCI battery was designed for sensitivity in MCI, which shares
effected domains with POCD. Radtke and colleagues utilized three CANTAB pre-tests of
pattern recognition memory (PRM), spatial recognition memory (SRM), and choice
reaction time. The PRM and SRM are designed to help prepare for the more robust PAL
test. The remainder of their battery consisted of tests administered orally (visual verbal
learning test and Stroop color word test). While the number of patients in their study was
respectable (n=1155), the differences in methodology could easily account for the
different findings.
The CODA trial was the second of the derived EEG guidance studies that have
similarities with this study.30 This study found higher POCD at 3 months (p=0.02) rather
than one week (p=0.06), opposite to the findings of our study, and much of the previous
literature. Although the findings are similar in that BIS-monitored care demonstrates less
POCD, the dramatic difference in early versus late findings could be related to the
neurocognitive battery utilized in the CODA trail. In addition, similar to the Radtke
study, there were a significant number of patients (n=99, 11%) who received macromolar anesthetic maintenance (propofol) along with the majority volatile anesthetic
group.
As mentioned, this is the first utilization of the complete CANTAB-MCI battery in
the study of POCD. The CANTAB-MCI was developed and tested in populations with
mild cognitive impairment. Our study demonstrates that the CANTAB-MCI is sensitive
enough to detect cognitive changes in the surgical anesthetic population. The study has

48

demonstrated ease-of-use and no burden for users in the perioperative environment. The
BIS-monitor allowed for anesthetic titration to low levels without experiencing an
episode of recall.
Limitations
Although this study had the strength of being a randomized, controlled study, it has
limitations. The primary limitation was the smaller sample size, which limited our ability
to determine any heterogeneity of treatment effect because we could not perform
subgroup analyses.
Conclusion
This study is important because it provides important data on patient
neurocognitive outcomes that will assist all anesthesia providers to make evidence-based
decisions about the optimal anesthetic techniques to promote best patient outcomes.
Careful titration, as guided by the BIS-monitor, by experienced anesthetic providers can
lead to a measurable improvement in patient outcomes. Taken in concert with previous
findings, our results suggest that BIS-guided anesthesia is safe, results in lower total
overall volatile anesthetic exposure and fewer disturbances in cognitive function and thus
should be considered by more providers as the standard of care.
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Table 3.1. Comparison of baseline characteristics among the three study arms (N=115)
Characteristics

Sociodemographics
Age, years
Female Gender
Caucasian
African-American
Other
Education
High school or some
college
College graduate and
greater
Annual household
income
<$25,000
$25,001-$75,000
>$75,001
Currently married
Surgical
Characteristics
Body Mass Index,
kg/m2
Premedication
None
Midazolam
Opioid
Anesthesia Time
ASA physical Status
Physical status 2
Physical status 3
Baseline systolic
blood pressure
Surgical procedure
Open Abdominal
Laparoscopic/Other
Posterior Lateral
Interbody Fusion
Minimally Invasive
Back

Total,
N=115

59.1 ± 6.7
74 (64.3)
105 (91.3)
7 (6.1)
3 (2.6)

Anesthesia
Anesthesia
Intervention,
Control,
n=39
n=40
Mean ± SD or n (%)
59.6 ± 6.8
24 (61.5)
35 (89.7)
2 (5.1)
2 (5.1)

58.5 ± 6.4
26 (65)
38 (95)
2 (5)
0

Healthy
Control,
n=36

P

59.1 ± 6.9
24 (67.6)
32 (88.9)
3 (8.3)
1 (2.8)

0.76
0.893
0.640

0.498
79 (68.7)

13 (33.3)

15 (37.5)

9 (25)

36 (31.3)

26 (66.7)

25 (62.5)

27 (75)
0.076

24 (20.9)
53 (46)
38 (33)
83 (72.2)

8 (20.5)
21 (53.8)
10 (25.6)
28 (71.8)

13 (32.5)
14 (35)
13 (32.5)
26 (65)

32 ± 8.1

31.4 ± 7.6

32.7 ± 8.6

3 (8.3)
18 (50)
15 (41.7)
29 (80.6)

0.319

0.489
0.084

29 (36.7)
13 (16.5)
37 (46.9)
3:30 ±
0:58

12 (30.8)
4 (10.3)
23 (59)
3:27 ± 0:57

17 (42.5)
9 (22.5)
14 (35)
3:32 ± 0:59

0.71
0.823

37 (46.8) 19 (48.7)
42 (36.5) 20 (51.3)
134 ±
15.8

133 ± 17.1

18 (45)
22 (55)
136 ± 14.5

0.387
0.394

20 (25.3)
13 (16.5)
31 (39.2)

9 (23.1)
9 (23.1)
13 (33.3)

11 (27.5)
4 (10)
18 (45)

15 (19.2)

8 (20.5)

7 (17.5)
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Table 3.2: Mean concentration of inspired and expired vapor, %
Intervention

Anesthesia-Control

Anesthetic
Vapor

Mean ± SD
inspired
concentration

Mean ± SD
expired
concentration

Mean ± SD
inspired
concentration

Mean ± SD
expired
concentration

Sevofluranea

1.78 ± 0.12 €

1.5 ± 0.17 ¥

2.45 ± 0.35 €

2.01 ± 0.19 ¥

Desfluraneb

4.54 ± 1.13 €

3.83 ± 0.64 ¥

6.13 ± 0.97 €

5.56 ± 1.93 ¥

Isofluranec

1.46 ± 0.9 €

1.1 ± 0.81 ¥

1.37 ± 0.35 €

0.9 ± 0.17 ¥

€ = p value of 0.002 for the interaction of group by inspired vapor; in post-hoc testing
using Bonferroni correction, a vs b p value is < 0.001; a vs c p value is 0.491; b vs c p
value is < 0.001.
¥ = p value of 0.006 for the interaction of group by expired vapor; in post-hoc testing
using Bonferroni correction, a vs b p value is < 0.001; a vs c p value is 0.713; b vs c p
value is < 0.001.
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Table 3.3: Neurocognitive function between 2 groups across time.
Neurocognitive
test and domain

Treatment/BIS
Mean ± SD

AnesthesiaControl
Mean ± SD

Overall p-value
Time main
effect
Interaction

Memory (non-verbalizable/patterns)
DMS Percent
Baseline
85.6±10
81.7±11.5
0.17
Correct
0.74
Time 2
83.1±12.6
78.3±16.7
Time 3
82.7±12
80.3±13.1
Memory (short term/visual)
PAL Total Errors Baseline
39.4±34.4
41.6±32.1
<0.001
Adjusted
0.02¥
Time 2
34.7±29.6
57.4±43.7
Time 3
25.7±21.8
33.2±30.5
PAL Total Errors Baseline
12±10.1
11.3±9.6
0.002
6 Shapes Adjusted Time 2
0.02¥
7.5±9.9
13.6±12.5
Time 3
6.6±5.9
8.3±9.3
Attention (visual sustained)
RVP A prime
Baseline
0.88±0.05
0.87±0.06
<0.001
0.58
Time 2
0.87±0.06
0.85±0.07
Time 3
0.89±0.05
0.89±0.06
RVP Median
Baseline
444.1±114.6
451.8±150.1
0.003
Latency
0.55
Time 2
498.3±179
518.8±218.3
Time 3
457.4±150.8
439.5±137.7
Processing speed/ latency
RTI Mean Simple Baseline
347.4±103.7
349.6±92.7
<0.001
Reaction Time
0.03¥
Time 2
390±88.4
438.6±117.7
Time 3
362±121.5
343.5±67.5
RTI Median
Baseline
309.3±54.7
316.4±59.1
<0.001
Simple Reaction
0.07
Time 2
355.7±61.6
394±84.4
Time
Time 3
312.6±56.1
319±51.4
RTI Median
Baseline
590.9±332.4
522.3±130.8
0.001
Simple Movement Time 2
0.15
576.3±145.2
615.7±216.4
Time
Time 3
494.9±86.9
485.7±97.4
RTI Median Five
Baseline
545.4±202.9
507.6±118.4
<0.001
Choice Movement Time 2
0.06
567.7±144.6
640.4±266.5
Time 3
486.1±84.7
474.1±94
Legend. DMS=Delayed Matching to Sample; PAL= Paired Associates Learning;
RTI= Reaction Time; RVP=Rapid Visual Information Processing; ¥ = Treatment
different from control (p<0.05).
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Table 3.4: Neurocognitive function among 3 groups across time
Neurocognitive
test and
domain

Treatment/BIS
Mean ± SD

AnesthesiaControl
Mean ± SD

Healthy
Control
Mean ± SD

Overall pvalue
Main
effect
Interaction

Memory (non-verbalizable/patterns)
DMS Percent
Baseline 85.6±10
81.7±11.5
84.7±10.8
0.5
Correct
0.3
Time 2
83.1±12.6
78.3±16.7
86.5±10.8
Time 3
82.7±12
80.3±13.1
87.5±10
Memory (short term/visual)
PAL Total
Baseline 39.4±34.4
41.6±32.1
34.1±30
<0.001
Errors
<0.001£
Time 2
34.7±29.6
57.4±43.7
25.6±27.1
Adjusted
Time 3
25.7±21.8
33.2±30.5
28±32.6
PAL Total
Baseline 12±10.1
11.3±9.6
10.1±9.2
<0.001
Errors 6
0.001
Time 2
7.5±9.9
13.6±12.5
4.6±7.6
Shapes
Time 3
6.6±5.9
8.3±9.3
8.4±9.6
Adjusted
Attention (visual sustained)
RVP A prime
Baseline 0.88±0.05
0.87±0.06
0.91±0.04
<0.001
0.03€£
Time 2
0.87±0.06
0.85±0.07
0.91±0.04
Time 3
0.89±0.05
0.89±0.06
0.91±0.06
RVP Median
Baseline 444.1±114.6
451.8±150.1 412.9±84.7
0.007
Latency
0.1
Time 2
498.3±179
518.8±218.3 406.8±69
Time 3
457.4±150.8
439.5±137.7 405.1±70.8
Processing speed/ latency
RTI Mean
Baseline 347.4±103.7
347±92.5
327.9±71.3
<0.001
Simple
0.1£
Time 2
390±88.4
435.9±118
369.3±118.8
Reaction Time Time 3
362±121.5
343.1±68.3 332.1±56.2
RTI Median
Baseline 309.3±54.7
316.6±59.8 304±60
<0.001
Simple
0.005£
Time 2
355.7±61.6
391.5±84
331.1±56.2
Reaction Time Time 3
312.6±56.1
319.3±51.8 310.3±44.6
RTI Median
Baseline 590.9±332.4
523.5±132.3 519±220.3
0.003
Simple
0.1
Time 2
576.3±145.2
617.5±218.9 510.8±105.6
Movement
Time 3
494.9±86.9
486.4±98.5 494.9±76.8
Time
RTI Median
Baseline 546.8±205.4
508.3±120
488±180.7
<0.001
Five Choice
0.005
Time 2
569.5±146.1
642.7±269.6 507.4±94.8
Movement
Time 3
487.1±84.7
474±95.2
503.3±77.4
Legend. DMS=Delayed Matching to Sample; PAL= Paired Associates Learning;
RTI= Reaction Time; RVP=Rapid Visual Information Processing; ¥ = Treatment
different from control (p<0.05); £ = Control different from normative (p<0.05);
€=Treatment different from normative (p,0.05).

53

Figure 3.1: CONSORT Diagram Patient Flow Through Study.
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CHAPTER FOUR
Predictors of cognitive dysfunction from a randomized controlled trial of EEG-guided
anesthesia compared to standard care
Introduction
Anesthetics are a critical component of health care. It is estimated by the Centers
for Disease Control and Prevention that over 51 million surgical procedures requiring
anesthesia were performed in 2010.1 Anesthetics have become a common occurrence in
society with risk perceived low by consumers. Improvements in safety have been
attributed to technology and standardization of monitoring.50 Recent studies suggest that
anesthesia-related mortality is 1.1 per million population per year.51 Still, the practice of
anesthesia seeks to evolve and improve patient outcomes.
Deficits in cognition have been reported for over fifty years.7 Post-operative
cognitive dysfunction (POCD) has been identified as a risk for individuals undergoing
surgery with volatile anesthetics.52 Post-operative cognitive dysfunction is defined as
negative changes in cognitive function that continue after appropriate drug half-lives
have expired. 53 Prediction of those patients likely to experience postoperative cognitive
dysfunction (POCD) after surgery could provide clinicians with information on important
risk factors for cognitive impairment.
Several large randomized controlled trials have described risk factors for POCD.
Most prominently, advanced age is described by many investigators as a principle
preexisting risk factor.3,54 The seminal study of POCD is the International Study of PostOperative Cognitive Dysfunction (ISPOCD 1).3 Lower education attainment, anesthesia
of extended duration, repeated operations, infections, and respiratory complications were
risk factors for POCD. History of substance abuse is also a preoperative risk factor for
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POCD.55 Predisposition to dementias (apoEε4 allele carriers) has been found to be a risk
factor in some studies,56 but not in others.57,58
We sought to evaluate a sample of patients who underwent surgery in a
randomized controlled trial of EEG-augmented anesthesia to determine if there are
baseline predictors of cognitive impairment at baseline and cognitive impairment after
surgery. The patients in this study are evaluated by the cognitive battery, Cambridge
Neuropsychological Test Automated Battery-Mild Cognitive Impairment® (CANTABMCI). This study represents the first time the complete battery was utilized to evaluate
patient outcomes after surgery with volatile anesthetics. Although many studies have
evaluated risk factors for POCD, the neurocognitive batteries employed in these studies
have required highly trained neuropsychologist.3,30,59 This study represents a practical
application of a cost effective neurocognitive battery.
Specific Aim 1: determine sociodemographic and clinical predictors of cognitive
function in patients planned for surgery utilizing volatile anesthetics and in a normative
group not undergoing surgery.
Specific Aim 2: determine sociodemographic and clinical predictors of cognitive
function in patients who have undergone surgery with a general anesthetic involving
volatile anesthetics
Methods
Design. This is a secondary, planned data analysis of the prospective, randomized
controlled trial, previously described in this dissertation. Parallel study groups underwent
anesthesia for select surgeries and completed the CANTAB-MCI pre-operatively and at
3-4 days after surgery and 3-5 months after surgery. The standard treatment group were
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anesthetized with volatile anesthetic and titrated with minimum alveolar concentration
(MAC) values. The patients in the treatment group were titrated utilizing the Bispectral
index™ system (BIS), an EEG-guided method of delivering anesthesia.
Sample and Setting. The sample consisted of 88 individuals, 45 individuals
randomized to the intervention and 43 individuals randomized to standard treatment.
Additionally, 37 age-and sex-matched individuals not undergoing surgery nor anesthesia
were followed with versions of the CANTAB-MCI at the same interval. We included
patient assessed as American Society of Anesthesiologist (ASA) class I-IV. These
patients were undergoing scheduled surgeries requiring general endotracheal anesthesia
with neuromuscular paralytic. Individuals for the normative group were included if they
were age 45-70, had not undergone surgery in the past 6 months, and had no surgery
planned. Only participants (patients and non-patients) who successfully completed the
Motor Screening (MOT) test, which demonstrates muscular and cognitive ability to
complete cognitive screening using the CANTAB-MCI, were invited to participate in the
study. Patients were excluded who had significant cardiorespiratory or other end-organ
disease, inadequate English language skills, and/or substance abuse. We also excluded
patients with known neurological conditions (i.e., stroke, pre-existing cognitive
dysfunction, and neuro-motor disabilities) and neurosurgical patients. We received
patient referrals from physicians and/or nurse practitioners working in the Preoperative
Clinic and surgeons in the medical center. Intervention. The intervention has been
previously described, but in brief, anesthetic technique in both groups included standard
induction with available agents, neuromuscular paralysis guided by nerve stimulator,
inhalation anesthetic, and intraoperative monitoring..
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BIS monitors were applied to both groups. The anesthesia provider in the standard
practice group was blinded to the BIS value. Titration and administration were performed
according to standard clinical practice judgment in both groups, but in the BIS group,
volatile anesthetic was titrated to maintain a BIS index range 45-60, but not less than 0.5
age adjusted MAC.
Measures
Demographic and clinical data. The following data were collected using a
standard questionnaire: Age, sex, race/ethnicity, education level, and annual income. The
patients’ current prescriptive medication regimen, comorbidities were obtained from the
preoperative anesthetic record. All drugs utilized during the procedure were recorded on
the anesthesia record and then transferred to a database for analysis.
Neurocognitive testing. The CANTAB-MCI system was used to measure
cognitive function in multiple domains, and is a computerized, touch screen based group
of 5 tests.
The CANTAB-MCI battery includes the Motor Control Task (MOT), Delayed
Matching to Sample (DMS), Rapid Visual Information Processing (RVP), Paired
Associates Learning (PAL), and Reaction Time (RTI). Reliability and validity of the
method has been established.42The MOT (2 minutes) is a simple introduction to the touch
screen for the participant. This task also functions as a screening test for visual,
movement and comprehension difficulties.
The DMS (DMS percent correct was used in this study) assesses cognition in the
memory domain for non-verbalizable patterns, testing both simultaneous and short term
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visual memory domains. DMS percent correct counts correct selections made on the
participant’s first response and higher scores are better.
The RVP (two outcome measures were used to reflect this domain, ‘RVP A’ ’ and
‘RVP median latency’) tests cognition in the visual sustained attention domain by
assessing the participant’s ability to recall a sequence of digits when given different
combinations of digits. The RVP A’ measures how good the participant is at detecting
target sequences and is scored (0.00 to 1.0; bad to good). The RVP median latency is
measured in milliseconds, and shorter is better.
The PAL (two measures were used to reflect this domain, ‘PAL total errors 6
shapes adjusted’ and ‘PAL total errors adjusted’) assesses cognition in the short
term/visual memory domain. For ‘PAL total errors adjusted’ lower scores are better, as
they are for the ‘PAL total errors 6 shapes adjusted’.
The RTI (RTI median simple reaction time was used to assess this domain) test is
a speed of processing/latency domain task. ‘RTI median simple reaction time’ is sensitive
for cognitive slowing, with lower scores reflecting better performance.
Protocol. The study proceeded after approval from the appropriate university
Institutional Review Board, and after informed consent was received. After successful
completion of the screening Motor Control Task (MOT), a full consent was completed
when the patient agreed to participate.
The CANTAB-MCI battery was administered in the patients’ hospital room,
service’s clinic, or location convenient to the patient before surgery (time 1), at 3-5 days
after surgery (time 2), and to ensure drug half-lives have expired. The battery was again
re-administered at 3-5 months (time 3) at a location convenient to the patient.
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Data Analysis
We determined sociodemographic predictors (i.e., group, age, gender, education,
income, and race) of cognitive function at baseline assessed in each of the four domains
studied using separate nonlinear regression models and a continuous level, gamma with
log link, response model. We initially attempted multiple linear regression modeling, but
the major assumption of a linear relationship between the independent variables and the
outcome variable was violated. Transformation of the outcome variable or appropriate
independent variables did not resolve this violation, thus, nonlinear modeling with SPSS
version 22 was done.
Because only the two surgical groups had pre-surgical clinical information
available, for time 2 (3-5 days after surgery) and time 3 (3-5 months after surgery), only
surgical patients were included in the nonlinear regression models for time 2 and time 3.
In order to optimize the model and avoid overfitting, we used only the sociodemographic
variables that were consistently significant (i.e., age, income) from the baseline models,
in the time 2 and time 3 models. Other predictor variables used in these time 2 and time 3
models were group, ASA status, procedure, tobacco use, and psychotropic drug
prescription. We tested a small number of other reasonable candidate predictors (i.e.,
diagnosis of diabetes, length of anesthesia, on beta-blockers preoperatively, body mass
index, and baseline blood pressure) for inclusion in the models, and compared the
Akaike Information Criterion (AIC) values to determine to best set of predictor variables
that resulted in the lowest AICs across the models.
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Results
Flow of participants through the study. We screened patients from October 2014
through June 2015 with the last follow-up completed in September 2015. Of the 329
patients screened for enrollment, 143 did not meet eligibility criteria and 98 chose not to
participate (Figure 1). Of the 88 patients scheduled for surgery who were enrolled, 45
were randomized to the intervention limb of the protocol and 43 were randomized to the
control protocol. Of the 45 patients allocated to the intervention limb, 2 (4.46%) were lost
to follow-up prior to the anesthetic. In the control limb, 1 (2.3%) was lost prior to the
anesthetic. Two patients from the intervention (4.46%) and control (4.6%) protocol limbs
were lost to follow up prior to their cognitive testing session 2. Two (4.46%) more
patients were lost to follow up prior to testing session 3 in the intervention limb of the
protocol. There was no difference in rate of withdrawal from the two surgical groups
(p=0.33). Patients who withdrew from the study were not significantly different than
patients who remained in the study on any of the demographic or clinical characteristics
measured at baseline including testing time 1 CANTAB-MCI® scores.
In addition we used purposive sampling to enroll an age- and gender-matched
healthy control sample. Seventy-two individuals were approached, with 10 not meeting
inclusion criteria and 25 refusing participation. Thirty-seven individuals were enrolled
with one lost to follow up prior to testing time 2.
Sample Characteristics. Of the 125 surgical patients and normative participants
available for analysis of cognitive outcomes at the last follow-up point (93% of the
enrolled sample), the mean age was 58.9 ± 6.7 years of age, the majority were female
(62.4%), and ethnicity coded as Caucasian 114 (91.2%). Sixty-eight percent had
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combined household incomes of less than $75,000 per year. The highest level of
education attained was at least some college in 69.5%. Demographic and clinical
characteristics of patients by total sample and group assignment are summarized in Table
1. There were no significant differences among the groups on any demographic or
clinical characteristic.
Specific Aim 1
We evaluated baseline sociodemographic (i.e., gender, age, education, income,
and race) predictors of POCD in a population of patients from a randomized controlled
trial utilizing BIS guidance versus standard care, and from a normative group who did not
undergo surgery. Controlling for group assignment, we demonstrated that older age was
predictive of poorer functional status at baseline in all of the dimensions measured except
RTI (Table 2). Lower income (less than $25,000 per year compared to greater than
$75,000) was predictive of worse cognitive function at baseline for the two cognitive
domains reflected by the ‘DMS Percent Correct’ and ‘RVP A’’ . Education level lower
than a completed college education was predictive of worse cognitive function in the
domain represented by the PAL. Caucasian race was associated with poorer cognitive
function compared to other races on the DMS. Gender was not associated with cognitive
function in any dimension tested, and neither was group assignment.
Specific Aim 2
In addition to group, in the analyses for Specific Aim 2 (post-operative cognitive
function), we used age and income as the sociodemographic predictors because (1) they
were the most consistent predictors in the previous analysis, (2) education and income
were highly correlated and thus, we thought it best to use only one of these predictors,
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and (3) given our relatively smaller sample size we were limited in the number of
variables that could be used as predictors. We used ASA status, surgical procedure
planned, tobacco use, and prescription for psychotropic drugs as clinical predictors, after
careful assessment of AIC values from different models.
With regard to predictors of cognitive performance on CANTAB-MCI testing at
time 2, (3-5 days after surgery) we found that, just as we found at baseline, older age and
lower income were predictive of worse cognitive function (Table 3). Assignment to the
EEG-guided anesthesia was associated with better cognitive function compared to the
control group. Patients in the EEG-guided group were 60% less likely to demonstrate
poor cognitive function than those in the control group. Other predictors of worse
outcomes were planned neurological or spinal surgery and tobacco use, prescription of
psychotropic drugs was not associated with cognitive outcomes.
Table 4 summarizes characteristics predictive at CANTAB-MCI testing three (3-5
months postoperatively). Assignment to the EEG guided group was associated with better
outcomes in the PAL measure at 3-5 months postoperatively. Again, older age and lower
incomes were predictive of worse cognitive function at 3-5 months after surgery. . Older
age was predictive of worse cognitive function as reflected by three outcome measures
‘DMS percent correct’,, ‘PAL Total Errors Adjusted’, and ‘RVP A’’ (p=0.001). The only
other predictor of poor outcomes at time three was lower income.
Discussion
In this study, we confirmed the results of our randomized controlled trial in that
patients in the EEG-guided anesthesia experienced better outcomes compared to those in
the control group. We demonstrated that a few variables that can be assessed prior to
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surgery are important predictors of cognitive impairment before and after surgery. .
Through each phase of assessment in this study, older age and lower income are
consistent predictors of poorer cognitive function. Our findings of advancing age and
low education/income reflect the findings of previous studies.4 Older age is thought to be
related to worse cognitive function due to decrements in cognitive function associated
with physiologic changes associated with the development of chronic illnesses (e.g.,
small vascular infarcts or ischemia) and the accumulation of effects of lifestyle choices
(e.g., smoking, hypertension, poor diet, sedentary lifestyle). Another possible contributor
is a cohort effect associated with lower education levels in current elders. In our study,
however, age was independently associated with cognition even when controlling for
education level.
An intriguing finding from our study was the effect of tobacco abuse on
postoperative performance on all four cognitive outcome measures, where we
demonstrated that tobacco abuse was associated with poorer cognitive outcomes at both
post-operative testing times. Although hypoxemia has been postulated as a causative
factor of POCD,60 the seminal randomized controlled trial of POCD (International Study
of Post-Operative Cognitive Dysfunction: ISPOCD1) found that hypoxemia was not
significant risk factors at any time.3 There were no significant episodes of hypoxemia
noted among smokers or nonsmokers in our study, nor reported postoperatively. It is well
known, however, that among nicotine-addicted smokers who attempt smoking cessation,
cognition and attention are impaired.61 In addition, smoking is associated with intensive
vasoconstriction, which may over time affect blood flow in the brain to produce subtle
yet progressive changes in cognition.
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The concern of the effect of tobacco abuse is amplified in this study. Beyond the
known cardiovascular and wound healing determents, this study finds that there are
cognitive effects at the time interval of 3-5 days postoperatively. These individuals have a
greater obstacle to overcome and have may have greater needs to be discharged. Their
ability to be included in new fast-track regimens such as the Enhanced recovery after
surgery (ERAS) protocol may be compromised.62 Nicotine effects continue to occur 3-4
days after individuals last partake of tobacco products. While it is recommended that
patients abstain from tobacco products six weeks prior to surgery, it is commonplace to
find patients who have smoked heavily immediately prior to admission for surgery.
Previous studies have suggested that mood stabilizing medication have effects on
cognitive performance.63,64 The use of psychotropic mood stabilizing medications did not
prove to be significantly predictive of post-operative function in this study. This may be
because other factors that were stronger risk factors for worse cognitive function
overshadowed the potential impact of mood stabilizing medications. Moreover, we did
not have dosage information or know the length of time patients were on these
medications.
Limitations
While the major strength is being a randomized controlled study, there are
limitations to the study. The major limitation is a smaller sample size. This limits our
ability to determine any heterogeneity of treatment effect because we could not perform
subgroup analyses.
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Conclusions
Older age, lower income and tobacco abuse are predictive of worse cognitive
outcomes, even in the company of specific procedural and clinical variables. All of these
factors are easily identifiable to even the busiest clinicians. Use of these characteristics in
the risk stratification of surgical candidates prior to surgery can assist healthcare
providers to target at-risk patients for early intervention to prevent cognitive morbidity.
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Table 4.1: Comparisons of baseline characteristics among the three study groups (N=115)
Treatment/BIS
n=45
Age

60 ± 7

AnesthesiaControl
n=43
58 ± 6

Normative
Group
n=37
59 ± 7

0.601

Gender: male

19 (42%)

16 (37%)

12 (32%)

0.659

Caucasian compared minority

41 (91%)

40 (93%)

33 (89%)

0.833

Annual household income
<$25,000
$25,001-$50,000
$50,000-$75,000
>$75,001
Education

P

0.075
8 (20%)
12 (29%)
11 (27%)
10 (24%)

13 (32.5%)
4 (10%)
10 (25%)
13 (32.5%)

3 (8%)
10 (28%)
8 (22%)
15 (42%)
0.279

High school or Less

15 (36%)

15 (37.5%)

9 (25%)

Some college or training

18 (43%)

10 (25%)

15 (42%

15 (37.5%)

12 (33%)

College graduate or more
9 (21%)
Legend: BIS = Bispectral™ index system

76

Table 4.2: Baseline sociodemographic predictors of baseline cognitive function in four domains from the CANTAB-MCI.
DMS percent correct

PAL Total Errors Adjusted

RTI Median Simple Reaction Time

RVP A’

Odds
Ratio [95% CI]

P value

Odds
Ratio [95% CI]

P value

Odds
Ratio [95% CI]

P value

Odds
Ratio [95% CI]

P value

Treatment/BIS

1.025 [0.97-.08]

0.384

0.967 [0.684-1.362]

0.848

1.006 [0.93-1.087]

0.885

0.979 [0.954-1.004]

0.095

Control/standard care

0.987 [0.931-1.045]

0.642

1.153 [0.817-1.625]

0.413

1.035 [0.955-1.123]

0.396

0.997 [0.94-0.992]

0.01

Gender: Male

0.973 [0.927-1.021]

0.26

1.109 [0.82-1.51]

0.505

1.014 [0.947-1.086]

0.686

1.003 [0.98-1.025]

0.8

Age

0.994 [0.99-0.997]

0.001

1.035 [1.015-1.056]

0.001

1 [0.995-1.004]

0.873

0.997 [0.995-0.999]

<0.001

High school or less

0.983 [0.919-1.05]

0.602

1.699 [1.132-2.552]

0.01

0.993 [0.904-1.09]

0.881

0.99 [0.962-1.02]

0.584

Some college or training

1.009[0.949-1.072]

0.776

1.579 [1.078-2.307]

0.018

1.061 [0.973-1.156]

0.178

0.995 [0.967-1.02]

0.703

<$25,000

0.925 [0.857-0.997]

0.04

1.351 [0.851-2.154]

0.2

1.07 [0.964-1.192]

0.198

0.995 [0.922-0.988]

0.008

$25,001-$50,000

0.987 [0.921-1.058]

0.711

1.312 [0.845-2.042]

0.224

1.005 [0.911-1.108]

0.926

0.982 [0.951-1.014]

0.255

$50,000-$75,000

0.998 [0.937-1.062]

0.937

1.172 [0.791-1.746]

0.427

0.974 [0.892-1.063]

0.547

0.98 [0.952-1.008]

0.154

0.912 [0.838-0.99]

0.028

1.27 [0.73-2.101]

0.37

1.003 [0.891-1.126]

0.955

0.992 [0.956-1.03]

0.693

Variable
Group†

Education ‡
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Income$

Caucasian £
(compared to all others)
Legend: BSI = Bispectral™ index system, DMS=Delayed Matching to Sample, PAL=Paired Associates Learning, RTI=Reaction Time, RVP A’=Rapid Visual Information Processing A
prime
Omnibus test: DMS p= 0.01; PAL p= 0.001; RTI p= 0.775; RVP p= <0.001.
Variable compared to: †= normative group; ‡=finished college or greater; $ = >$75,000; £= all others

Table 4.3: Baseline sociodemographic and procedural predictors of cognitive function within 3-5 days after surgery in four
domains measured from the CANTAB-MCI battery.
DMS percent correct
Odds
Ratio [95% CI]

P

PAL Total Errors Adjusted

RTI Median Simple Reaction Time

RVP A’

Odds
Ratio [95% CI]

P

Odds
Ratio [95% CI]

P

Odds
Ratio [95% CI]

P

Variable
Group†
BIS

1.058 [0.98-1.15]

0.18

0.595 [0.41-0.87]

0.008

0.91 [0.84-0.98]

0.018

1.01 [0.98-1.05]

0.38

0.989 [0.91-1.1]

0.84

0.800 [0.54-1.19]

<0.001

1.03 [0.95-1.12]

0.42

1.01 [0.98-1.04]

0.466

Neuro/spin

0.876 [0.78-0.98]

0.026

1.695 [0.99-2.89]

0.053

1.18 [1.06-1.33]

0.003

0.95 [0.91-0.993]

0.024

Colorectal

0.928 [0.8-1.07]

0.32

1.642 [0.84-3.22]

0.148

1.16 [1.01-1.34]

0.036

0.95 [0.894-0.998]

0.043

General surgery

0.923 [0.8-1.07]

0.29

1.483 [0.75-2.93]

0.258

1.24 [1.08-1.43]

0.003

0.95 [0.894-0.999]

0.044

0.992 [0.985-0.999]

0.02

1.06 [1.03-1.1]

<0.001

1.01 [1.001-1.014]

0.027

0.99 [0.99-1]

0.107

1.202 [1.11-1.3]

<0.001

0.618 [0.43-0.89]

0.003

0.89 [0.82-0.96]

0.004

1.03 [1.005-1.07]

0.023

<$25-25

0.983 [0.88-1.1]

0.78

2.152 [1.25-3.69]

0.006

0.993 [0.89-1.11]

0.90

0.96 [0.92-1.001]

0.053

$25-$50

1.028 [0.91-1.16]

0.66

2.086 [1.15-3.79]

0.016

1.037 [0.92-1.17]

0.54

0.95 [0.91-0.996]

0.033

$50-$75

0.986 [0.89-1.1]

0.799

1.874 [1.15-3.06]

0.012

0.967 [0.87-1.07]

0.53

0.96 [0.92-0.995]

0.027

ASA score‡
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ASA 2
Procedure‽

Age
Tobacco use ₮
No Tobacco use
Income $ K

Table 4.3 Continued
DMS percent correct
Odds
Ratio [95% CI]

P

PAL Total Errors Adjusted

RTI Median Simple Reaction Time

RVP A’

Odds
Ratio [95% CI]

P

Odds
Ratio [95% CI]

P

Odds
Ratio [95% CI]

0.974 [0.67-1.43]

0.89

0.999 [0.92-1.09]

0.99

1.03 [1-1.07]

P

Psychotropics £
None

1.078 [0.99-1.17]

0.08

0.051

Legend: CI=Confidence interval, DMS=Delayed Matching to Sample, PAL=Paired Associates Learning, RTI=Reaction Time, RVP A’=Rapid Visual Information Processing A
prime.
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Omnibus test: DMS p=0.001; PAL p= <0.001; RTI p=0.007; RVP p=0.002.
Variable compared to: †= control/standard care group; ‡=ASA3&4; ‽ Laparoscopic;₮=smoker; $ = >$75,000; £= Psychotropic use

Table 4.4: Baseline sociodemographic and procedural predictors of cognitive function within 3-5 months after surgery in
four domains measured from the CANTAB-MCI battery.
DMS percent correct
Odds
Ratio [95% CI]

P

PAL Total Errors Adjusted
Odds
Ratio [95% CI]

P

RVP A’

RTI Median Simple
Reaction Time
Odds
P
Ratio [95% CI]

Odds
Ratio [95% CI]

P

Variable
Group∂
BIS

0.032 [-0.028-0.99]

0.268

0.16 [-0.73—0.063]

0.02

0.037[-0.079-0.6]

0.833

0.0119 [-0.02-0.26]

0.795

0.0334 [-0.067-0.06]

0.961

0.1703 [-0.33-0.34]

0.993

0.038 [-0.06-0.8]

0.816

0.001 [-0.005-0.001]

0.001

ASA score‡
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ASA 2
Procedure‽
Neuro/spine

0.0461 [-0.034-0.15]

0.222

0.241 [-0.642-0.3]

0.477

0.05 [-0.03-1.17]

0.187

0.017 [-0.06-0.005]

=0.091

Colorectal

0.0594 [-0.065-0.17]

0.385

0.3128 [-0.67-0.56]

0.859

0.068 [-0.9-1.17]

0.602

0.022 [-0.08-0.005]

0.08

General surgery

0.0608 [-0.172-0.07]

0.383

0.317 [-0.53-0.717]

0.761

0.068 [-0.056 -0.2]

0.256

0.022 [-0.09-0.01]

0.019

0.0135 [0.05-0.104]

<0.001

0.003 [-0.004-

0.593

0.001 [-0.01-0.001]

0.001

0.079

0.0119 [-0.01-0.042]

0.119

Age

0.003 [-0.014--.003]

0.001

0.008]
Tobacco use ₮
No Tobacco use

0.0325 [-0.018-0.11]

0.164

0.1723 [-0.44-0.24]

0.569

0.037 [-0.14-0.007]

Table 4.4 Continued
DMS percent correct

Odds

PAL Total Errors Adjusted

P

Odds

Ratio [95% CI]

P

Ratio [95% CI]

RTI Median Simple
Reaction Time
Odds

P

Ratio [95% CI]

RVP A’

Odds

P

Ratio [95% CI]

Income $
<$25,000

0.044 [-0.24--0.063]

0.001

0.2412 [0.002-0.95]

0.049

0.049 [-0.87-1.108]

0.833

0.016 [-0.095-0.03]

<0.001

$25,001-

0.048 [-0.156-0.031]

0.19

0.2602 [0.29-1.31]

0.002

0.979 [-1.127-

0.691

0.018 [-0.09-0.019]

0.002

0.0425 [-0.103-0.63]

0.637

0.2236 [-0.13-0.75]

0.168

0.084]

0.466

0.016 [-0.046-0.02]

0.33

$50,000
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$50,000$75,000

1.043 [-0.0590.129]

Legend: CI=Confidence interval, BIS = Bispectral index system. DMS=Delayed Matching to Sample, PAL=Paired Associates Learning, RTI=Reaction
Time, RVP A’=Rapid Visual Information Processing A prime.
Omnibus test: DMS p=0.004; PAL p= <0.001; RTI p=0.83 ; RVP p=0.001.
Variable compared to: ∂=Diabetic ; ‡=ASA3; ‽ Laparoscopic;₮=smoker; $ = >$75,000.

CHAPTER FIVE
Background and Purpose
Over 51 million Americans underwent surgery in the last reported year.1 The
fastest growing proportion of individuals are the elderly, and are the largest consumers of
surgery.2 The development of postoperative cognitive dysfunction (POCD) after surgery
is an important complication of surgery for many patients, likely more than appreciated
by clinicians. Volatile anesthetics (e.g., isoflurane, sevoflurane, and desflurane) have
been implicated in the development of POCD by triggeringneuroinflammation.14,20,21 This
cognitive decline is associated with increased one-year mortality, as well as morbidity
and family/caregiver stress.4
The overall purpose of this dissertation was to determine whether an anesthetic
technique, with less cumulative deep hypnotic time, results in fewer individuals with
POCD. A large obstacle in the better understanding of POCD is that the exact mechanism
of volatile anesthetics is still not known. To better understand this void, the manuscript in
chapter 2 was developed and is a review of the current concepts of anesthesia
mechanisms and the neuropathogenic effects on the aging brain was done.
Based on findings from this manuscript, a randomized controlled trial of
anesthesia guided by BIS vs. standard care and effects on cognition was undertaken, and
was reported in Chapter 3. This randomized control trial of 115 individuals undergoing
anesthesia (39 patients whose anesthesia delivery was guided by Bispectral Index®
system [BIS-Covidien-Medtronic™] and 40 who received standard care) was conducted
from August 2014-September of 2015. The group whose anesthesia was guided by the
BIS system was predicted to have a lower overall cumulative dose of volatile anesthetic
than their standard care counterparts. After this trial, we conducted a secondary,
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preplanned, data analysis (reported in Chapter 4) to determine risk factors for POCD
among the surgery patients enrolled in the clinical trial.
EEG derived systems have been developed to measure depth of consciousness
and enable the anesthesia provider to tailor anesthetics to the individual patient. Recent
findings from studies utilizing the BIS system have demonstrated this titration is
associated with positive outcomes in reduction of postoperative deficits.30,32 However,
these studies have some limitations with regard to the measurement and reporting of
cognitive function. This dissertation was innovative and resolved some gaps in the
literature because we used the Cambridge Neuropsychological Test Automated BatteryMild Cognitive Impairment (CANTAB-MCI®), an instrument with known reliability and
validity in a wide variety conditions, including the measured of pre- and post-operative
cognitive function. This battery is delivered on a state of the art touch screen system and
is highly regarded as one of the most rigorous methods of measuring cognitive function
because it provides measurement of all relevant domains, and is objective and not open to
investigator bias in interpretation.
Summary of Findings
Chapter Two was a focused review of the state of the science in the understanding
of the mechanism of volatile anesthetic function. Beyond the Meyer-Overton theory, the
protein theory of volatile anesthetic mechanism seems most plausible. The manipulation
of gamma-aminobutyric acid (GABA) receptor proteins and the known inhibitory effect
of chloride ion channels seem to be the machinery of anesthetic function. Still, bench
scientists have produced additional examples of volatile anesthetic effect on proteins,
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such as, N-methyl-D-aspartate receptors,65 and potassium channel subfamilies TREK1
and TASK66.
Studies to elucidate POCD have largely followed the affected cognitive domains.
The association of POCD with mild cognitive impairment (MCI) has led researchers to
compare the sequela of volatile anesthesia with the neuropathogenesis of the
dementias.67 Pathways including apoptosis,68 oligomerization,14 and caspase activation15
have all been demonstrated with appropriate doses of volatile anesthetics, mimicking
dementia neuropathogenesis. These close relationships between the dementias and the
current concepts of anesthesia mechanism pose grave concern. Still, there is not a
consensus on types of drugs, techniques, nor ways to monitor in mitigation of POCD.69
Chapter Three is a report documenting a randomized controlled trial evaluating
the effect of EEG guided anesthesia via the BIS monitor on cognitive function in surgical
patients. In a sample of 86 individuals, 45 surgical patients randomized to the
intervention of a balanced anesthetic technique with BIS guidance, and 43 to standard
treatment. Cognitive performance was evaluated with the Cambridge Neuropsychological
Test Automated Battery-Mild Cognitive Impairment (CANTAB-MCI®) at three intervals
(preoperatively, 3-5 days post-operatively, and 3-5 months post-operatively).
Our findings demonstrate statistically significant differences in two outcome
measures of the Cambridge Cognition Paired Associates Learning (PAL) test. The PAL is
a test of the short term/visual memory domain. The outcome measures ‘PAL total errors
adjusted’ (p=0.02) and ‘PAL total errors 6 shapes adjusted (p=0.02) were both
significantly different in the time by group comparison at 3-5 days, but not at 3-5 months.
A two-way mixed repeated measures ANOVA was utilized to address this specific aim.

84

The BIS group had significantly better cognitive outcomes at 3-5 days than did the
treatment group who has a deficit in cognitive function in this domain after surgery.
Cognitive function returned to baseline in both groups by the 3-5 month assessment. An
additional 37 age- and sex-matched individuals not undergoing surgery nor anesthesia
were evaluated at the same intervals to represent a normative population. This study
demonstrated that EEG guided anesthesia can reduce cumulative deep hypnotic time
without negatively affecting patient physiologic stress or surgical conditions, while at the
same time preventing cognitive dysfunction in some domains.
Chapter Four is a dissemination of a analysis of predictors of cognitive function
from the randomized controlled trial, Chapter 3. Baseline predictors of poorer CANTABMCI test performance to include older age and lower income regardless of group. At the
second time period, the BIS guided treatment proved protective (p=0.008) for cognitive
impairment, while older age and lower income remained predictive of worse cognitive
function. At the long-term measurement period, older age, lower income, and assignment
to the control group were associated with poorer outcomes. These findings are reflect
larger studies, but were obtained with the cost-effective CANTAB-MCI system.4
Impact of Dissertation on the State of the Science
Health care, and its extraordinary cost, is a constant conundrum facing the United
States and the world. Over the last 50 years, healthcare costs in the United States has
escalated from 5 percent of GDP in 1960 to 17.4 percent in 2013.70 Many initiatives have
been utilized to impact this escalation while seeking to preserve and improve patient
outcomes. Recently, the Centers for Medicare & Medicaid Services (CMS) and
America’s Health Insurance Plans (AHIP) released their first set of clinical quality
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measures as part of their Core Quality Measures Collaborative also known as “pay for
performance.” This initiative seeks to replace diagnosis-related groups (DRG) and
International Statistical Classification of Diseases and Related Health Problems (ICD) as
the central component for healthcare reimbursement. In the Core Quality Measures
Collaborative, along with length of stay, factors such as controlling hypertension, timely
screening, and appropriate medication regimens increase reimbursement.71 Over the last
decade, a surgical practice model has evolved to address the same issues of balancing
cost with quality. Enhanced Recovery After Surgery (ERAS®) is a set of multimodal
care guidelines that include all facets of a surgical patients’ perioperative experience.62
The ERAS® initiative drastically alters standard tenants of surgical care including
reducing preoperative fasting, encouraging minimally invasive surgical approaches, and
multimodal approaches to anesthesia care. The goal of ERAS® is prevention of physical
and metabolic decline thereby allowing patients to recover more quickly. The ERAS®
begins preoperatively with patient preparation and teaching, extends through the
surgical/anesthetic phase, and includes critical components postoperatively through
discharge/follow-up. Initial evaluations of the guidelines resulted in significantly
improved morbidity and mortality (28.4% and 1.6% respectively) from previously
reported studies (35% and 2%) (p=<0.0001 and p=0.156).72 In the past five years, the
surgical approach has been extended successfully to other surgical practices.73-75 Patient
participation, motivation, and communication are critical to the ERAS® approach.
Patients unable to fully participate due to cognitive dysfunction postoperatively limit the
ultimate effectiveness of the total approach.
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This dissertation represents an important contribution to the literature as it is the
first study to show that the CANTAB-MCI battery is effective in discriminating the fine
difference in cognitive burden between two groups who underwent the stress of surgery.
The CANTAB touch screen based system did not produce an undue burden on the
patients, staff, nor require an unreasonable expenditure of time. The finding of significant
differences in group performance on the Paired Associates Learning (PAL) test suggest
that the BIS guided anesthesia technique may present some sparing effect on the integrity
of the temporal lobe, especially the entorhinal cortex, as this area is critical for
performance in the PAL.76
Prior investigators have demonstrated that POCD is associated with higher
morbidity and mortality.4 It is well established that cognitive decline, such as that seen in
MCI, is associated with increased mortality.44 The causative relationship of cognitive
decline to mortality is not clear. Bassuk and collegues44 clearly state that cognitive
decline may, “interfere with the ability to recognize signs and symptoms of disease, to
seek timely medical assistance, to adhere to a medication regimen, to prepare adequate
meals, and to engage in other preventive health care behaviors.” While there is no clear
relationship between POCD and MCI, the similarity of domains affected and
neuropathology is telling. In concert with these data, our data suggests that early POCD,
even when transient, may identify patients who are vulnerable to later morbidity and
mortality. If future studies support this association then those individuals with early
POCD could be targeted for intervention to reduce later morbidity and mortality. Patients
identified should have a multidisciplinary team who evaluates and forms a patient
specific treatment plan targeted at optimal survivability.
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Recommendations for Nursing Practice and Research
The outcome of this dissertation suggests utilization of a BIS-guided, balanced
anesthetic technique is effective in reducing effects of volatile anesthetics on
postoperative cognition. Although many groups including the young and healthy may not
present as at risk for POCD, the old, elderly, and frail should call for increased
discrimination in the preoperative setting. Still, it is critical, that salient effects of
anesthetics may still be occurring sub-clinically. Individuals with parents diagnosed with
Alzheimer’s disease, known predisposition to dementias (apoEε4 allele carriers), and
cerebral vascular disease should be counseled and anesthetic approach weighed against
these risk. Utilization of cognitive batteries, such as, the CANTAB-MCI® can be utilized
in these at risk populations when there is no other option for general anesthesia as a
means to ascertain domains which may be affected.
This study found susceptibility for deficits in visual memory/learning in
individuals undergoing anesthesia with high cumulative hypnotic time. This was found at
the 3-5 day time, but not in the late 3-5 month time. This finding is similar to that of
larger studies of POCD.59 This presents a concern with patients undergoing healthcare
teaching/discharge planning in this same time interval. Situations where patients receive
complicated instructions or procedures they must understand to care for themselves at
home may be lost due to cognitive deficits.
The results of this and other studies suggest that special attention needs to be
given to discharge education and that follow-up by phone or early return visits to the
surgeon or primary care provider are warranted. All discharge instruction should be
explained to a family member or friend as well as to the patient. In addition, specific,
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clear instructions should be written out. It is common for written discharge instructions
to be “generic” or not specifically tailored to the patient. Given the potential for
cognitive impairment after surgery, this practice should be avoided.
Additional studies are planned to expand upon this study. For example,
integrating a more complete understand of the neurocognitive effects of volatile
anesthetics into the ERAS® approach and testing the outcomes of such integration should
lead to interesting findings. The old and the elderly, are at highest risk for poor outcomes
in regard to POCD4 and surgical morbidity,77,78 therefore, it is prudent to approach these
populations with great care.72 Further study, integrating the EEG guided anesthesia
technique described in this dissertation, that is focused on improving outcomes in elders
is warranted.
Given the previous studies which have shown an association between POCD and
higher morbidity and mortality in the long-term, it is interesting to speculate whether
interventions could be specifically targeted to patients who experience POCD early after
anesthesia. Our finding of early POCD in a specific domain suggests that even with
apparent recovery of POCD, patients who experience early POCD may represent a
vulnerable subset of patients who may experience worse outcomes in the long term.
Further research is suggested to test this possibility and further refine interventions to
improve outcomes after surgery.
Conclusions
We were able to demonstrate a practical anesthesia technique can have an
important impact on patient outcomes. While volatile anesthetics are a very important
component of current anesthetic practice, evidence is substantial that they are not benign.
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The Bispectral Index system is one of several EEG guidance systems that are prevalent
throughout the United States. Their utilization in individuals identified to be at risk for
cognitive decline after anesthesia (advanced age, low education/socioeconomic status,
and tobacco abuse) is warranted, but all patients ultimately deserve the best care
delivered in the optimal manner and thus, we recommend use of EEG guided anesthesia
for all patients. The CANTAB-MCI system demonstrated rugged reliability, sensitivity,
and ease of use. Utilization of this cognitive battery as a screening to, especially for at
risk groups, could allow providers to follow these patients and personalize their care for
their best outcomes.
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